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Compartmentalization of cell body from the axon of a neuron is an important aspect 
in studying the influence of microenvironments. Microenvironment is an integral part of 
neuronal studies involving traumatic axonal injuries (TAI). While TAI is one of the 
possible outcomes of various forms of traumatic insults to the central nervous system 
(CNS) and peripheral nervous system (PNS), many of the mechanistic details are still 
unknown, it can be agreed that the level of injury often dictates the functional deficit. This 
motivates the question, what is occurring at both the morphological and biomolecular scale 
in CNS and PNS axons during and throughout the recovery phase after injury? And, are 
there any treatment strategies that could be applied to improve the recovery and 
regeneration of the axons subject to TAI? Motivated by this, I propose to develop novel 
microfluidic platforms as a part of my master’s thesis to allow unprecedented, 
physiologically relevant focal and graded mechanical injury and observation to both CNS 
and PNS axons.  
 
My research for this thesis can be broadly classified into two fold. 1) I examined 
the regenerative effects of the members of the Glial cell line-derived neurotrophic factor 
(GDNF), a family of neurotrophic factors after axotomy. This work resulted in the 
discovery of the fact that GDNF is the most potent neurotrophic factor among the family 
of growth factors for axon regeneration in dorsal root ganglion (DRG) neurons after in 
vitro axotomy. It was also found that GDNF locally applied to cell body better promotes 
axonal regeneration in comparison to when applied locally to axons. 2) Development and 
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refinement of existing axon injury microplatform (AIM) to closely mimic physiological 
conditions during traumatic injury in CNS neurons. This work was my attempt in 
improving already existing microfluidic compression platform. I successfully developed a 
displacement control injury device and demonstrated displacement control as a proof of 
principle. Further development of these microfluidic platforms will significantly contribute 
to the field of basic neuroscience, neurobiology, and biomedical engineering.  
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This work is an effort to understand and elucidate few of the molecular and 
structural dynamics of axonal injuries and the subsequent fate of axons post injury: to 
undergo either regeneration or degeneration, and to develop novel microfluidic platforms 
for neuroscience. This work can further be sub-classified into axonal injuries in Central 
Nervous System (CNS) and Peripheral Nervous System (PNS). Evidence from literature 
suggests that axonal regeneration in CNS is non-existent but is a fairly common 
phenomenon in PNS, given the right conditions. Recently it was found that the CNS axons 
do not inherently lack the regeneration abilities; rather, it is the environment that they grow 
and survive in is not conducive of regeneration. This opened new avenues into the research 
on axonal regeneration in CNS. Though axon regeneration in PNS has been established in 
the past, those studies are limited by the highly dynamic nature of the events at molecular 
level in vivo. 
 
In vivo animal models of trauma, either to CNS or PNS permits the study of whole 
organism’s response to a multitude of complex variables and behavioral outcome studies. 
Multiple injury modalities like Instant rotational injury model, Impact acceleration injury 
model, Lateral fluid percussion injury model, Controlled cortical impact model, Nerve 
stretch model [1] etc. exist for in vivo settings. These models facilitate monitoring of 
prognosis, and functional outcome to various treatment strategies. Though extremely 
useful, these models do not shed light on events at single cell and molecular level. To a 
2 
 
reductionist, in vivo techniques offer highly complex information leaving with the 
alternative of in vitro techniques. In vitro models on the other hand allow the study of 
biochemical pathways, gene expression levels, and phenotypic changes at single axon 
resolutions. To attain single axon resolutions in vitro, compartmentalization of soma from 
axons is needed. Attempts towards compartmentalization of neurons in vitro started couple 
of decades ago with the use of neurons with long axons like that of PNS. But those 
techniques were limited by the size of neurons and their axons rendering them not useful 
for the study of CNS neurons. Micro electro mechanical device (MEMS) technology 
integrated with biological applications gave raise to bioMEMS and Lab on Chip (LOC) 
devices which facilitated the required compartmentalization of axons from soma in these 
CNS neurons.  
 
1.1 Compartmentalization studies of axons and soma 
While neurons have been cultured and studied in vitro for decades, the idea of 
compartmentalized cultures did not become not mainstream until the late 70’s. The first 
attempt at compartmentalization of neurons with segregation of soma and axon into 
physically distinct and chemically separate compartments was successfully established by 
Campenot [2, 3]. These chambers were made on a Petri dish by coating a layer of grease 
on the bottom of the dish and laying a reusable Teflon layer on top of the existing silicone 
grease layer. The grease layer acts as a hydrophobic barrier which enables the 
establishment of chemically distinct microenvironments for soma and axon of PNS 
neurons. These devices were successfully used for several studies ranging from axonal 
transport to regeneration. Ivins et al. [4] also developed a compartmentalized chamber 
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using coverslip as a physical barrier in separation of soma and axons in culture. These 
devices are not versatile for compartmentalized neuronal studies owing to the complexity 
involved in fabrication and maintenance. Nevertheless, these studies [2-9] pioneered a new 
era of compartmentalized culture systems in neuroscience and neuroengineering. 
 
1.2 Microtechnology in neurobiology and neuroscience 
Effective use of microfluidics in neuroscience started with miniaturization of 
Campenot chambers. This miniaturized version of Campenot chamber is much needed 
because of the complexities involved with its fabrication and application for various studies 
that involve neurons with axons of shorter lengths like in the case of CNS. With an array 
of parallel microfluidic channels connecting two chambers which otherwise are not 
connected is developed by Taylor et al. [10]. Well established photolithography techniques 
widely used for MEMS were used to define a master template in silicon wafers which are 
replica molded in poly(dimethylsiloxane) (PDMS) to make these devices. This started a 
new avenue for research in neurobiology and neuroscience. 
 
The development of a dual chamber microfluidic device for neuroscience research 
by Taylor et al. [10] spawned interests in further developing various kinds of microfluidic 
platforms for neuroscience research. Microfluidic platforms and devices for neuroscience 
can be broadly classified into 1) electrical interfaces, 2) chemical interfaces, 3) physical 
interfaces, and 4) interface integrating any combination of the other three interfaces[11]. 
These platforms are being widely applied to culture neurons, manipulate neurons with the 
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flexibility of manipulating cell body and axons independent of each other, neuronal stem 
cell differentiation, neuropharmacology, neuroelectrophysiology, neuronal biosensors, and 
disease models [12, 13]. These microfluidic platforms are also extensively used in studies 
involving various types of neuronal supporting cells like Schwann cells, astrocytes, 
oligodendrocytes and even microglia. A brief summary of the microfluidic interfaces and 
their applications can be found in table 1.1 and a further emphasis on multicompartment 
chambers can be found in chapter 2. 
Table 1.1: Microfluidic interfaces for neuroscience and neurobiology research 
Interface Applications 
Electrical Interfaces Neuroelectrophysiolgy, Multi electrode arrays, stimulation, 
electro-chemical detection etc.  
Chemical Interfaces Neuropharmacology, disease models, fluidic isolation, soluble 
gradients, chemical guidance etc. 
Physical Interfaces Surface patterning, axon guidance, disease models, stem cell 
differentiation, neuronal co-culture studies, 
compartmentalization studies etc. 
Combined interfaces Neuronal biosensors, neuronal co-culture studies, 
compartmentalization studies, axon regeneration, electrical 





With this impetus several LOC platforms were developed. LOC devices provide 
powerful alternatives to existing in vivo and in vitro techniques in studying Traumatic 
Axonal Injuries (TAI). Providing platforms to model and study at single cell resolutions 
with compartmentalization and precise control over cellular microenvironments. They can 
be automated, require little amount of reagents with a scope for multiplexing, and high 
throughput[14]. LOC devices have been developed for neuroscience applications ranging 
from injury settings that can be employed in neuroscience to model and study the injuries 
and regeneration, synaptic connectivity, and complex live neural networks [15-20] as they 
can achieve fluidic isolation of the neuronal cell bodies from their axons. Several kinds of 
microfluidic devices are developed for the applications in neuroscience [12, 21-25].  
 
LOC devices are also broadly employed in neurobiology for neuron cell culture, 
neuron manipulation, neural stem cell differentiation, neuropharmacology, and neuro-
electrophysiology. With respect to axon injury studies, microfluidic platforms are highly 
compatible with different modes of injuries. Broadly classified, the modes of inducing 
injuries in neurons on these platforms are:  I. Physical, II. Chemical, and III. Both I and II. 
Physical modes include employing laser ablation techniques [26-28], valve based 
compression of axons[29], microsurgeries and axotomy. On the other hand chemical 






1.2.1 Microfluidic platforms for in vivo injury models 
1.2.1.1 Injury mode: Physical 
LOC platforms, a great tool for reductionist approach are also extensively 
employed to study axon regeneration in vivo. Many model organisms like Aplysia 
californica, Caenorhabditis elegans, Drosophila, and zebrafish are used in the studies of in 
vivo neuron injury and regeneration [26-28, 30-32]. Amongst these, C. elegans is a 
nematode with its genome completely sequenced and with a feasibility of in vivo axotomy, 
offers a powerful model to study in vivo nerve injury and regeneration.  Immobilizing the 
worm and subjecting it to axotomy is a critical step in studying the injury and regeneration. 
Conventional techniques of immobilization employ the use of glue, and anesthetics. 
Though these modes are typical for immobilizing the worm, they have some drawbacks. 
These methods can either have unknown toxic effects that are difficult to evaluate or are 
labor intensive and of low throughput. Microfluidic platforms can be a clever alternative 
to these problems. Choksi et al. [27] has developed microfluidic platforms to immobilize 
single worms on either a short term or long term basis to characterize their on-chip 
behavior.  Chung et al. [26] designed and developed an automated, integrated microfluidic 
system to perform high-throughput cell microsurgery. Their device is capable of processing 
multiple worms in parallel without increase in control complexity. The device can be used 
to simultaneously load worms in one set of channels and perform imaging and laser 
ablation in the other set. Guo et al. [28] has developed a high throughput microfluidic 
platform for in vivo nerve regeneration studies. Their platform enables precise focusing 
and nano surgery of trapped worms and feeding for recovery of the operated worms in two 
different modules. The device also incorporates an adjustable trap for immobilization of 
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worms at various developmental stages. Highly specific laser ablation techniques can be 
used to injure the worms once they are steadily immobilized. Based on the frequency or 
the repetition rate of laser, the gaps created in the axotomy vary. With high frequency lasers 
2-5 µm gaps are created where as low frequency lasers result in precise 1-2 µm gaps[31, 
33]. Other physical modes of causing injury to axons  in vivo involve needles to transect 
individual axons, fluid percussion, microelectrodes etc. [34].  
 
1.2.2 Microfluidic platforms for in vitro injury models 
1.2.2.1 Injury mode: Physical 
Stretch induced injury is one of the many modes of physical injury observed in vivo 
during traumatic insult to axons of CNS and PNS. Several groups have modeled and 
studied these injuries in vitro. Stretch-induced injury model [35] on cortical astrocytes (of 
brain origin) was developed by culturing the cells on deformable membrane which was 
subjected to deformation by a positive rapid pressure. The system enables to study the 
extent and degree of injury with precise control over deformation of membrane by varying 
the amplitude and duration of pressure. Speaking of axons specifically, one of the major 
hurdles for them to undergo regeneration in an injury setting is the enormous lengths that 
they would have to grow to bridge established between the proximal extending axon and 
the distal stump. In bridging these gaps, axons have to circumvent the non-permissive 
substrates for neurite growth. Myelin of oligodendrocytes is a potent inhibitor for neurite 
outgrowth in CNS. In addition to this, glial scar formed at the site of an injury acts as both 
mechanical and biochemical barrier for the growing axons. As the name suggests the scar 
is often comprised of glial cell types like reactive astrocytes, microglia, oligodendrocyte 
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precursors, and fibroblasts. It also contains growth inhibitory factors such as semaphorins, 
ephrins, tenascin and chondroitin sulfate proteoglycans [36]. This non permissiveness can 
be a kind of negative mechanism involved in enhancing the efficiency of surface 
recognition process for selective cell and growth cone migration. The non-permissive 
nature of the myelin and oligodendrocytes can be attributed to membrane proteins of 35 kd 
and 250 kd, which can be extracted from CNS myelin fractions. Antibodies: IN-1 and IN2 
raised against these proteins neutralized the non-permissiveness of the myelin and allowed 
the axon outgrowth[37]. The growth rate of axon also plays a major role in bridging the 
gap in regeneration. One of the several strategies to influence a sustained but rapid growth 
in axons is to apply a continuous mechanical tension. Smith et al. [38] developed a device 
to physically split integrated neuronal cultures into two halves and separate the halves 
progressively further apart using a microstepper motor system. In doing so they achieved 
a growth rate of 1mm/day. Transecting axons to induce axonal injury by laser ablation in 
one of the physical modes [33, 39]. Kim et al. [11] developed a neuro-optial microfluidic 
platform that integrates a microfluidic chip, femtosecond laser for axotomy and mini-
incubator to maintain sterile and appropriate microenvironment for long term monitoring 
of events post injury.  
 
1.2.2.2 Injury mode: Chemical 
Traumatic injuries to axons of CNS and PNS can be induced by chemicals like 
neurotoxins, neurotransmitter in excess (excitotoxicity), and detergents [30, 34]. Injury 
induced by chemicals in microfluidic platforms aid both the qualitative and quantitative 
study, as the concentrations can be varied and localized precisely. Several in vitro axon 
9 
 
injury models have been developed to study chemically induced injury. Kilinc et al.[26] 
developed a three compartment (cell body, cenral/proximal, distal compartments) 
microfluidic device to study simultaneous axonal degeneration and death mechanisms of 
axons subject to axotomy, with precise spatiotemporal control. The injury was induced by 
a brief and isolated flux of detergent in the central compartment. They observed rapid 
Wallerian-like degeneration in the distal axons subject to axotomy. Li et al. [22] developed 
an integrated microfulidic platform to chemically induce axonal injury and study the 
recovery and regeneration of axon either in co-culture with glial cells in controllable 
chamber using valves or treatment with monosialoganglioside, a drug aiding neuronal 
regeneration.      
 
Other important aspect of the events post injury are survival, recovery and 
regeneration of the axon. Microfluidic platforms are an excellent choice for studying and 
understanding the mechanisms involved in regeneration or degeneration post injury, 
establishment of neural networks. Several strategies to achieve this in microfluidic devices 
have been devised [40-45]. For example a gradient-generator microfluidic device was 
developed by Bhattacharjee et al. [32]. This device helped to study the neuronal response 
to diffusible gradient. This helps to understand the complex mechanisms of axon growth 
and guidance to chemical gradients. Microfluidic devices have been developed to study 
synapse formations as they provide a suitable platform to analyze the cellular events 





1.3 Specific Aims 
The specific aims of my research have the following interests. First, I aimed to 
study the role of Glial cell line-derived Neurotrophic Factor (GDNF) in the axonal 
regeneration post injury in simple two chamber microfluidic devices. Second, I aimed at 
improving the existing microfluidic technologies that allows focal and graded axonal injury 
to incorporate three dimensional injury models and novel displacement control injury 
models. Specifically, I have divided the research into the following aims: 
Aim 1. To study the role of GDNF as a neurotrophic factor in axonal regeneration post 
injury of PNS neurons in simple two chambered, open system, microfluidic devices. 
Aim 2. To design and optimize three dimensional microfluidic platforms for a focal and 
graded compressive injury to axons, and to develop microfluidic chambers in a manner 
compatible with high resolution optical microscopy. 
 
1.4 Organization of the Thesis 
This thesis is organized into 5 chapters dealing with the aims presented above. 
Chapter 1 gives a brief introduction about microtechnologies for axonal injury studies in 
various settings. Chapter 2 deals with a review of literature in multichambered microfluidic 
devices in neuroscience with specific applications in axonal injury and regeneration. 
Chapter 3 and chapter 4 describe the experimental working of aims with brief 
introductions, materials and methods, results, discussions and conclusions associated with 
each aim. Chapter 5 consists the conclusions of the work and project some ideas about 
future possibilities and potential areas of development. Finally, an appendix with protocols 
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Microfluidic Multi-Compartment Chamber Devices in 
Neuroscience and Neuroengineering 
 
2.1 Introduction 
Neurons are highly polarized cells with a cell body ‘soma’ and processes ‘axon’ 
and ‘dendrites’: axon constitutes the majority of protoplasm in a neuron. By this intrinsic 
nature of polarization, neurons are usually seen extending their axons, often several 
millimeters into varying microenvironments in their niche. These processes constantly 
encounter various guidance cues in varying degrees from the surrounding 
microenvironments in the form of biochemical, and biophysical signals for growth, 
maintenance and remodeling. These microenvironments encountered by axons in their 
process of extension more often than not differ in chemical and physical properties in 
comparison to the microenvironment surrounding soma. Well established and traditional 
in vitro cell culture techniques in petri dish are reliable in elucidating phenomenon 
affecting on a global scale by bathing soma and axons homogenously in a culture media[47, 
48]. But they usually fail about providing invaluable information on much localized 
phenomenon which are equally powerful in advancing our understanding of neurobiology. 
And so, it is only imperative to develop novel in vitro neuronal culture platforms that can 
establish and enable tailoring of these varying microenvironments for successful 
maintenance and study of the cultures in close resemblance to in vivo systems. With the 
advent of and advances in sophisticated photo lithography techniques for semi-conductor 
industry, a field of study integrating mechanical systems with electrical systems called 
13 
 
MEMS emerged. MEMS further branched out into biological MEMS (BioMEMS) with 
potential applications in various fields of biology. 
  
BioMEMS integrated with microfluidics emerged as Laboratory-on-a-Chip (LOC) 
platforms: potential and viable alternatives for existing techniques to conduct various 
biological studies at micron scales with precise control over the micro environments. The 
broad spectrum applications of microtechnology has involved engineers[11] in 
collaboration with biologists to develop several novel LOC devices for various studies[11, 
12, 49-53]. These microfluidic systems initiated a new era of studies in biology by 
efficiently reducing the volume of reagents and samples there by the overall cost 
incurred[54], and by facilitating spatiotemporal manipulation of a system at cellular 
dimensions. With the reduction in system size, phenomena like diffusion, surface tension, 
and viscosity play a prominent role counterintuitive to our experiences with the 
macroscopic world [55, 56]. These microscale phenomena can be exploited for several 
practical purposes like establishing and maintaining interfaces, gradients, and even 
manipulation and processing of droplets in real time for biochemical analysis[57]. 
Microtechnology also offers potential and viable platforms for investigations in 
neuroscience. The operation range of neurons fall under the bounds of LOC devices with 
the possibility of incorporation of electrodes for stimulation and recording, microchannels 





Soft lithography in elastomeric polymer PDMS is one of the most sought after 
techniques for fabricating LOC devices. Soft lithography encompasses rapid prototyping 
and replica molding: rapid prototyping of a master template in positive relief is achieved 
by photo lithography (a commonly used microfabrication technique) and a pre polymer of 
PDMS is cast and cured on the master template for replica molding. Using this technique, 
structures and features ranging in sizes from 100 nm to 100 μm can be transferred on to 
PDMS with great fidelity. Many studies involved the development and use of LOC devices 
in PDMS consisting of elements like micro channels, pumps, mixers and valves[61]. 
Several groups have fabricated LOC devices in PDMS for neuroscience studies including 
neuronal cultures, in vitro disease models, and electrophysiology. 
 
We present you in this review, a comprehensive view of recent developments of 
various multi-compartment LOC devices for neuroscience used across studies involving 
neuronal cultures, in vitro disease models, and electrophysiology.  We explore various 
LOC devices in this review by organizing the discussions in the following way: (1) 
Fabrication, and (2) Multi-Compartment Chamber Devices. 
     
2.2 Fabrication 
Microfluidic devices were conceived as early as 1970s in the form of a miniaturized 
gas chromatograms[62] serving as an impetus for present day LOC devices. The initial 
microfluidic devices were developed in silicon and glass, based on then existing technology 
for MEMS. They were commonly applied in chemical analysis, gradually making their 
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impact felt in biological applications with the development of BioMEMS. BioMEMS 
enabled medical and biochemical analysis with increased resolutions, increased density in 
arrays, massive parallelization, high throughput, and decrease in volume of the reagents 
being used. BioMEMS combined with the advances in soft lithography spawned LOC 
devices. The fabrication of these devices is usually done in PDMS elastomer which offers 
several advantages: PDMS as a material of fabrication is a viable choice because of its low 
interfacial energy (can be bonded to most surfaces reversibly), chemical and thermal 
stability (does not react with the surfaces it comes in contact with), permeability to gases 
(allows gaseous exchange to maintain viable cell cultures), optically transparent down to 
230 nm (compatible with imaging), mechanically deformable (for incorporation of valves, 
pumps), tunable interfaces (hydrophobic/hydrophilic), and of most importance is its 
inertness and biocompatibility[63].    
 
2.2.1 Design and Fabrication Techniques 
Limitations like the cost of operation, compatibility with nonplanar surfaces, 
suitability for surface chemical modification, and choice of photoresists render the well-
established photolithography technique not so useful for LOC applications. In contrast, soft 
lithography offers to overcome the limitations that are encountered in conventional 
photolithography. Soft lithography includes photo lithography to create a master template 
in positive relief by rapid prototyping. First a layout of the device design is developed using 
Computer Aided Design (CAD) and this CAD file is used to print a high resolution 
transparency mask (up to a resolution of 5 μm). A 3-4 inch Si wafer is spun with SU8 
photoresist to a desired thickness, exposed with the mask and developed. The features left 
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on the surface of the Si wafer serve as positive relief patterns of the master template in 
downstream processes as illustrated in figure 2.1 A. 
 
The later part of soft lithography involves developing elastomeric PDMS molds 
from the master templates by cast molding. The pre-polymer of PDMS is made available 
in a two part kit comprising of a base and a catalyst/curing agent. The ratio of base to the 
curing agent can be altered to tune desired mechanical properties of the cross-linked 
PDMS. A desired mixture of base and curing agent is prepared, degassed and cast on the 
master template. The cast pre-polymer is then incubated for couple of hours in an incubator 
for the cross linking reaction: hydrosilylation between the vinyl and hydrosilane groups. 
The cast is cooled and peeled off from the master template for next cycle of cast molding 
[64]. The mold produced can be used in various techniques like microcontact printing 
(μCP), replica molding, micro-molding in capillaries (MIMIC) and few others [63-67]. In 
μCP, the relief structures in PDMS are used as stamps in transferring patterns to the surface 
of a substrate by contact, resulting in micro patterns and this method has been used often 
to pattern ECM substrates (figure 2.1). In MIMIC a PDMS mold consisting of parallel 
grooves is used to create empty channels when in contact with the surface of a substrate. 
These empty channels act as capillaries and when a liquid of low viscosity is seeded at one 
end it is taken up across the channels by capillary action. MIMIC is another soft lithography 
technique to pattern surfaces (figure 2.1 B). These techniques in conjunction with LOC 




2.2.2 Modeling and Simulations 
The scaling down of neuronal culture system’s dimensions to an order of microns 
not only improves the operation cost and handling, but also allows the precise control of 
microenvironments with a possibility of compartmentalization. The scaling down of 
dimensions to micron orders results in significant changes to the physics of fluids that are 
seldom perceived at macroscopic scales [55-57, 68]. The continuum theory of fluids still 
holds at micron scales for channel dimensions >100 nm. Often cited paradigm to delineate 
Fig 2.1: A. Schematic of photolithography technique and micro contact printing (adapted from [64] 
copyright 2010 Nature Publishing Group), B. Schematic of MIMIC technique (adapted from [67] 
copyright 1996 American Chemical Society). 
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the significant deviations in fundamental physical properties at micron scale is mass 
transport phenomena. Mass transport in microfluidic channels is primarily dominated by 
viscous forces but not by inertial forces, which are almost negligible resulting in laminar 
flow profile in the channels. When the microfluidic channel dimensions are further reduced 
below 100 nm, we enter the regime of nanofluidics. The continuum theory can still be 
applied here by excluding few layers of molecules adjacent to the channel walls. The 
physics of nanofluidics further varies significantly from that of microfluidics and this is 
discussed elsewhere [68-72].  
 
Several non-dimensional numbers are used when describing the physics of 
microfluidics: Reynolds number, Péclet number, Knudsen number, capillary number etc. 
In this review we briefly focus on the first three dimensionless numbers which help in 
understanding the dynamical physical properties of microfluidic neuronal culture systems.  
The culture medium is assumed to be a Newtonian fluid and that it obeys Navier-




+ 𝐮. ∇𝐮) =  −∇p + η∇2𝐮 + 𝐟 
𝜌 − 𝑑𝑒𝑛𝑠𝑖𝑡𝑦   p − 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒   𝜂 − 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑖𝑛𝑡 𝑜𝑓 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦    
𝐮 −  𝑓𝑙𝑜𝑤 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 𝑣𝑒𝑐𝑡𝑜𝑟   𝐟 − 𝑏𝑜𝑑𝑦 𝑓𝑜𝑟𝑐𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑖𝑒𝑠    
19 
 
Inertial forces in microfluidic systems are of negligible order compared to viscous 
forces. This implies that the non-linear term in Navier-Stokes equation, 𝐮. ∇𝐮  can be 
neglected. Combined with mass conservation yields the incompressibility condition 
∇𝐮 = 𝟎. 
 
The loss of non-linearity in microfluidics results in low Reynolds number (Re) 








𝑓𝑖 − 𝑖𝑛𝑒𝑟𝑡𝑖𝑎𝑙 𝑓𝑜𝑟𝑐𝑒 𝑑𝑒𝑛𝑠𝑖𝑔𝑦   𝑓𝑣 − 𝑣𝑖𝑠𝑐𝑜𝑢𝑠 𝑓𝑜𝑟𝑐𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 
 
𝜌 − 𝑓𝑙𝑢𝑖𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦   𝑢 − 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦   𝐿 − 𝑡𝑦𝑝𝑖𝑐𝑎𝑙 𝑙𝑒𝑛𝑔𝑡ℎ 𝑠𝑐𝑎𝑙𝑒    
𝜂 − 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑖𝑛𝑡 𝑜𝑓 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦  
Low Re number flows are not common on macroscopic scales but are frequently 
encountered in microfluidics. The low Re number in microfluidic devices results in 
predictable Stokes flow in the channels. The no-slip boundary condition in pressure driven 
flows ensure that the flow velocity of fluid is zero at walls resulting in a parabolic profile 





The second dimensionless number is the Péclet number. Péclet number signifies 
the solute transport: the mixing and maintenance of gradients in microfluidic channels. It 





𝑤 − 𝑐ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐 𝑙𝑒𝑛𝑔𝑡ℎ   𝑈 − 𝑓𝑙𝑜𝑤 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦    
𝐷 − 𝑚𝑎𝑠𝑠 𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
Mixing may or may not be desired in the neuronal culture system. In the case of 
compartmentalization, mixing is not usually desired and a steady gradient of solute 
molecules, like growth factors are needed to guide axonal growth. Low Pe number results 
in diffusion dominated mixing which helps maintain a gradient for a long time in culture 
system. 
 
Another dimensionless number is the Knudsen number. Knudsen number is defined 
as the ratio of mean free path of molecules to macroscopic length scale. Knudsen number 
defines the transition of fluid approximation from continuum to discreet molecules. It 
establishes the validity of continuum Navier-Stokes equations.  




𝜆𝑓 − 𝑚𝑒𝑎𝑛 𝑓𝑟𝑒𝑒 𝑝𝑎𝑡ℎ 𝑓𝑜𝑟 𝑐𝑜𝑙𝑙𝑖𝑠𝑖𝑜𝑛𝑠   𝐿 − 𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑠𝑖𝑡𝑖𝑐 𝑙𝑒𝑛𝑔𝑡ℎ 
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The dimensionless numbers mentioned above elucidate the physical phenomena 
operating in microfluidic systems. They define system performance parameters and help 
in developing mathematical models to numerically simulate the system. Numerical 
simulations of microfluidic systems are not only an excellent research tool but also they 
play a vital role in efficient design, prototype development and optimization. Mathematical 
models developed for numerical solutions and simulations can easily incorporate the 
complexities of channel geometry, fluid flow rates, flow profiles, diffusion coefficients, 
dynamic gradients, their spread in space and time, and possible chemical interactions to 
great details. An accurate prediction of the behavior of a particular system can be made 
using the models and simulations which are otherwise elusive on a preliminary 
examination to our intuition. Mathematical modeling and simulations also further our 
theoretical understanding of the physics of microfluidic systems which are otherwise hard 
to realize in experiments and practice. 
 
Mathematical models of these systems are powerful tools or substitute for 
eliminating the need for laborious experiments to determine optimal conditions by 
changing any number of parameters on the performance of the device without actually 
fabricating different devices. But the caveat is that mathematical modeling is an 
approximation of the physical phenomenon in play (often some physical phenomenon are 
not accounted for or left out for the sake of simplicity) and the simulations often fail to 




Finite Difference (FD) method, Finite Volume (FV) method and Finite Element 
Modeling (FEM) are few approaches commonly used to model microfluidic systems. All 
these methods are relatively similar in that they spatially discretize differential equations 
over a solution domain[73, 74]. FD method is usually employed in the cases of well-
structured grids with simple geometries by converting partial derivatives to numerically 
solvable differential equations[75, 76]. FV method is similar to FD in the sense that the 
system is divided into a series of control volume nodes and each node is treated as an 
independent entity.  A system of differential equations are written out for each node, 
treating the adjacent nodes as unknowns and these equations are numerically integrated 
[77-79]. The arbitrary geometry of the nodes makes FV more generic over FD but 
difficulties often arise in establishing the system of governing differential equations and 
reducing them to a lower order. Also, FV methods are more suitable for systems where 
viscous forces are negligible, but in the realm of microfluidic systems where viscous forces 
play a major role, FV method is rendered complex and not feasible. This leaves us with 
FEM as promising method for simulating microfluidic systems. 
 
Like FV method, FEM has the advantage of dealing with arbitrary and irregular 
node geometries. FEM begins with discretizing the sample space into finite and spatially 
distinct series of interconnecting nodes and elements collectively representing the overall 
geometry of the system. FEM can handle unstructured grids and irregular geometries like 
linear, triangular, parabolic etc. The partial differential equations for each node is set using 
techniques in variational calculus. These partial differential equations are then given 
weights in FEM which are multiplied prior to the integration over the domain. The relative 
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ease and simplicity with which one can establish even weak formulations and apply 
boundary conditions makes FEM one of the best sought after method for modeling in 
microfluidic simulations. Nevertheless, necessary caution is to be taken when applying 
FEM methods as they suffer from cumbersome numerical computations associated with 
the irregular and arbitrary geometries.  FEM has been not only used to model various flows 
(non-uniform surfaces, free surfaces, capillary and immiscible flows), mass transfer and 
mixing (dispersion, gradients), heat transfer (dissipation, gradients), electrophoresis etc., 
in microchannels [73, 80-83] but its significance is being felt and utilized in modeling 
gradients in gels established in microchannels , the characterization and optimization of 
microfluidic device mechanical properties etc. [61, 83, 84] . 
 
2.3 Multi-compartment Chamber devices in Neuroscience and Neuroengineering 
While neurons have been cultured and studied in vitro for decades the idea of 
compartmentalized cultures did not become mainstream until the late 70’s. The first 
attempt at compartmentalization of neurons with segregation of soma and axon into 
physically distinct and chemically separate compartments was successfully established by 
Campenot [2, 3]. These chambers were made on a Petri dish by coating a layer of grease 
on the bottom of the dish and laying a reusable Teflon layer on top of the existing silicone 
grease layer. The grease layer acts as a hydrophobic barrier which enables the 
establishment of chemically distinct microenvironments for soma and axon. These devices 
were successfully used for several studies ranging from axonal transport to regeneration. 
Ivins et al. also developed a compartmentalized chamber using coverslip as a physical 
barrier in separation of soma and axons in culture. These devices are not versatile for 
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compartmentalized neuronal studies owing to the complexity involved in fabrication and 
maintenance. Nevertheless, these studies pioneered a new era of compartmentalized culture 
systems in neuroscience and neuroengineering. 
 
With the development of BioMEMS and LOC devices the compartmentalization of 
neurons in culture has been achieved with a relative ease compared to the traditional 
Campenot and Ivans culture systems. Before we discuss any further on the advancements 
of LOC devices for compartmentalized studies we should address the important question: 
Why do we need the compartmentalization of neurons? The following reasons listed below 
should briefly address this question 
a. The neurons in CNS extend over considerable distances through varying extracellular 
microenvironments to from synapses, the basis of neuronal connectivity. 
b. Etiology of several neurodegenerative diseases and CNS injuries involve axonal 
damage (for example spinal cord injury and Alzheimer Disease). 
c. Campenot chambers were not successful in culturing CNS neurons involved in the 
pathology of most neurodegenerative diseases and injuries (for example, cortical, 
hippocampal, and spinal cord neurons). 
d. Selective isolation of the axonal molecules (for example, axonal mRNA, protein 
machinery etc.) from mammalian CNS neurons, an achievement not possible by either 
in vitro or in vivo methods. (Axonal protein synthesis is important in the development, 
maintenance, and plasticity of synapses) 
e. To model axonal injury: the ability to selectively lesion axons and biochemically 
analyze their somata for immediate early gene expression. 
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f. Co-culture studies of oligodendrocytes with CNS axons to study the myelination as 
well as demyelination diseases like MS. 
g. For selective axonal transport studies. 
 
2.3.1 Multi-compartment Chamber devices for axon guidance  
The complex circuitry of a human brain involves highly intricate yet structured 
architecture of connections between individual neurons enabled through functional 
synapses. The interconnectivity between neurons through functional synapses is often so 
dense that single neurons are seen networking with several neurons, in the order of 
hundreds to thousands both in the vicinity and remote areas. A functional connection 
between two neurons is established via synaptogenesis: a multi-step complex and dynamic 
process which involves several events at cellular and molecular level like elongation and 
polarity of neurites, axon path finding/guidance, target recognition and signaling within 
presynaptic and postsynaptic components. Axon guidance involved in synaptogenesis 
plays an important role in normal and pathogenic brain development as well as in 
neurological regenerative and/or degenerative medicine. Several disorders linked with or 
implicating faulty axon developmental pathways like autism are being discovered and the 
number is growing [85]. Similarly, neurodegenerative diseases like Alzheimer’s, 
Parkinson’s, Huntington’s, and prion diseases are associated with synaptic and neuronal 
dysfunction. Directionality of neuronal pathways in developmental mechanisms of specific 
connections and degeneration of neuronal networks in mature brains has elicited the 
interests of several neurobiologists to pursue explorative studies involving molecular 
processes pertaining to axon guidance, functional synapse formation, maintenance, and 
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plasticity. In vivo methods best preserve the architecture of neuronal connectivity offering 
realistic and physiological insights into axon guidance, synapse formation and remodeling. 
However, the sheer number of connections and the complexity associated with mammalian 
brains serve as road blocks for in vivo methods. Resorting to in vitro culture techniques 
offer alternatives to achieve this feat. Nevertheless, traditional in vitro techniques with two 
dimensional dissociated cultures, even with small number of cells result in random 
connections and three dimensional organotypic culture vary from sample to sample and 
often the connections are severed in slice preparation. Novel LOC microfluidic platforms 
are being developed in the recent years to study axon guidance and synapse formation in 
vitro owing to the several advantages they offer over traditional methods. 
 
Traditional in vitro culture methods lack the sophistication to conduct studies with 
spatial compartmentalization of neuronal signals: they do not offer separation of axons 
from soma to study the local molecular mechanisms involved in axon guidance, and fail to 
preferentially orient neuronal networks with several neuronal subtypes. Also, they suffer 
from the lack of complexity in providing a localized plethora of axon guidance cues like 
canonical guidance cues, morphogens, growth factors, cell adhesion proteins, and the 
extensive cross talk that is often observed between various guidance pathways. These 
hinder elucidation of the underpinnings of phenomena involved in complex axon guidance 
and neuronal networks. With recent technological advancements in microfabrication novel 
and innovative LOC devices for axon guidance and functional synapse formation studies 
are being developed. The guidance cues in these devices can be i. Physical [86-89], ii. 
Chemical [90-93], iii. Or both [86, 92, 93]. Physical cues for guidance often involve 
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microchannels with various shapes and geometries, which act as conduit for axons to grow 
and orient. Physical cues can either maintain or realign the current orientation of axons as 
axons are considered to be stiff and when encountered with barriers they reorient 
themselves with altering growth rates. Chemical cues can either be growth promoting like 
neurotrophic factors or growth inhibiting like scar tissue, myelin etc. In order to act as 
guidance cues these chemical cues are usually presented to the axon growth cone in 
gradients. The gradients can either be soluble or insoluble, and they can be stable over time 
or dynamic i.e. the gradients can be spatiotemporally controlled to guide the axonal growth 
cones.  
 
Takayama et al. [86] developed a LOC platform to form a one-way-structured 
cultured neuronal network that is functionally regulated. Combining microfluidic devices 
with microcontact printing their device consists of U-shaped array structure for cell 
trapping in PDMS which is bonded to a previously patterned glass substrate by 
microcontact printing with areas of cell adhesive and non-adhesive molecules. Once cells 
were trapped in the device, the cells were exposed to chronic medium flow rates (0.5 
μl/min) to study the effects on the direction of neurite elongation. Their study indicates the 
fact that a chronic medium flow could positively affect the direction of neurite development 
and can be useful for forming morphologically and functionally regulated cultured 
neuronal networks. Mahto et al. [87] developed a three compartment microfluidic device 
to study functional synapse formation in vitro. The microfluidic device is made up of three 
parallel compartments, while the middle compartment is narrower and is connected to side 
compartments with microgrooves that define the directionality of neuritis. The functional 
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synapses were established by first culturing cells in the side compartments. Once neurites 
to extend via microgrooves into the middle compartment, fresh cells are seeded into the 
middle compartment which establish a functional network between the two channels. Pirlo 
et al.  [88] a microfluidic system with asymmetric geometries to study neuron-neuron and 
neuron-glia interactions. They developed a laser cell deposition system to selectively seed 
cells into a specific microwells interconnected with channels of asymmetric geometry that 
promote neurite extension and formation of functional synapses. The device geometry 
permits a unidirectional and functional network formation between neurons and also allows 
co-culture studies with glial cells. Peyrin et al. [89] developed a compartmentalized 
microfluidic platform called axon diodes for oriented and unidirectional neuronal networks 
of high complexity. The microfluidic platform consists of two chambers interconnected 
with funnel shaped asymmetric channels called axon diodes that taper down along the 
length which ensures that the axons penetrate only in one direction resulting in the 
unidirectionality of the network established. Functional and highly oriented binary 
neuronal networks between different types of neurons can be easily established with this 
device.  
 
Shi et al. [90] developed a compartmentalized microfluidic chamber with 
multicomponent, protein-micropatterned surfaces to investigate local crosstalk between N-
cadherin and fibroblast growth factor receptor in axon guidance. The chamber design, a 
microchannel barrier overhang on the cell side suits aggregate cultures like explants or 
embryoid bodies better than dissociated cell cultures. Millet et al. [91] developed a 
multicompartment microfluidic device to pattern tunable surfaces for axon guidance. The 
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device design consists of three parallel channels with the middle channel interconnected to 
the two peripheral channels via microchannels, allowing establishment of biologically 
more relevant substrate diffusion gradients in combination with more tunable and dynamic 
fluid-phase laminar flow gradients. Using this device they established differential substrate 
patterns of stable, surface-bound gradients of laminin and Texas Red-conjugated bovine 
serum albumin (TR_BSA) perpendicular to binary FITC-PLL lines for preferential 
neuronal polarity and axon guidance. Kothapalli et al. [92] designed and fabricated a 
microfluidic device to study axon guidance. The device design permits the study of 3D 
neuronal culture closely evoking native cell responses. The microfluidic device is a 
multicompartment device with a T-shaped gel region at the intersection of three 
microfluidic channels: media, cell, and guidance channels. Stable soluble gradients of 
guidance cues were established across the gel, orthogonal to the direction of neurite growth 
in as little as 30 min and maintained stable over a period of 48 hours, impervious to external 
perturbations. Bhattacharjee et al. [93] conceptualized and implemented a neuron-benign 
gradient-generator multicompartment, microdluidic device to study axon guidance. The 
device design incorporates a large, central open reservoir for cells with parallel source and 
sink microchannels on sides, interconnected orthogonally by smaller microchannels called 
microjets. This design ensures negligible flow in the open reservoir resulting in minimal 
shear-stress to the cells and thereby improving the viability of cultures, hence neuro-
benign. Stable gradients of guidance cues are established across the source, reservoir and 
sink by laminar flow of media with a certain concentration guidance cue in the source 
microchannel while the media flowing in sink microchannel carries no guidance cue. Stable 
diffusible surface gradients are established between the two boundary concentrations 
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within 2-5 min and are stable up to 6 hours, the shear-force to which the neurons are 
exposed due to the flow in gradient creation is negligible. 
Fig 2.2: 1a & 1b. In vitro reconstruction of a neuronal network using ‘‘axonal diodes’’ in microfluidic 
culture devices, 1c & 1d. Immunofluorescent images of microfluidic neuronal cultures either on the 
wide or the narrow side, 1e. Quantification axonal growth polarization (adapted from [89] with 
permission from The Royal Society of Chemistry), 2a & 2b. Design of the three-channel microfluidic 
device developed to study neurite turning in 3D scaffolds under a growth factor gradient, 2c, 2d & 2e. 
Neurite guidance of hippocampal neurons by chemoattractants (adapted from [92] with permission 
from The Royal Society of Chemistry), 3a. Schematic of micro-jets device with a central open-surface 
reservoir, 3b & 3c. Neuronal response to netrin (adapted from [93] with permission from The Royal 
Society of Chemistry), and 4a & 4b. Schematic of the channel design used and diffusion through 
microfluidic interconnects, 4c & 4d. Traces of neuronal process in gradients and control (adapted from 
[91] with permission from The Royal Society of Chemistry). 
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2.3.2 Multi-compartment Chamber devices for axonal biochemical analysis and 
assays  
The characteristic polarity of a neuron with soma, dendrites, and an axon(s) enables 
formation of complex circuitry with highly defined directionality in chemical 
communication between neurons, information processing, storage, and retrieval. Earlier, it 
was thought that axons were devoid of protein synthesis machinery for biosynthesis of 
proteins and other molecules, and that the synthesis occurs solely in soma and the finished 
products are translocated either actively or passively to axon [94]. The selective transport 
of synthesized proteins in soma only to axons undergoing synaptic changes is hard to 
explain without local protein synthesis in axons. Recent evidences supporting local protein 
synthesis in axons [95] are increasing in number indicating the necessity to selectively 
study the mechanisms of proteins synthesis and transport in axons with no interference 
from soma. Disruption of axonal transport is observed in pathology of several 
neurodegenerative disorders like Alzheimer’s, Huntington’s, and Parkinson’s. Also, axonal 
degeneration and neuronal apoptosis is closely linked with mitochondrial transport. All 
these evidence points to the fact that the analysis of axonal transport, mRNA pool, protein 
synthesis etc. sans somal counterparts is paramount. 
 
Traditional neuronal culture techniques involved culturing of either dissociated 
neurons or explants in petri dishes. The sense of compartmentalization and fluidic isolation 
is not maintained in these cultures and it was extremely hard to isolate and study the 
biochemical processes in axons. Identified solely by the morphology, axons were randomly 
oriented in all directions and often entangled. Often the sense, i.e. retrograde or anterograde 
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is extremely hard and painstaking to identify in these cultures. They are not high-
throughput, scaling up is labor intensive and often difficult. Microfluidics and LOC devices 
are right up the alley and address several of these issues in neuroscience and 
neuroengineering. The dimensions of these devices are similar to that of neurons in vivo 
and the provide compartmentalization and fluidic isolation. This enables the study of 
localized axonal mechanisms without even the slightest interference from somal 
compartment. Several groups have developed novel LOC devices to study transport, 
protein synthesis and biochemical analysis in axons and functional synaptic junctions [96-
102]. 
 
Millet et al. [97] developed multicompartment microfluidic devices, both with open 
and closed channel systems to study the microenvironments of neurons in culture at low 
densities. Ability to culture neurons at low densities enables one to specifically isolate the 
microenvironments of axons for biochemical analysis. With the option to perfuse, 
collection of samples from the microenvironment is spatiotemporally controlled. Noo Li 
Jeon group [96, 98, 101, 102] developed several variations of multicompartment 
microfluidic devices to study various aspects of axonal transport, axonal mRNA and axonal 
translates. The basic device design consists of two microfluidic compartments one each for 
soma and axon interconnected by microchannels. Hydrostatic pressure driven fluidic 
isolation can be achieved for a period of 48 hours in these devices which permits the 
collection of axonal fraction without and interference from the cell body compartment. In 
some cases, to increase the axonal fraction output, the closed soma chamber was made 
open to achieve high density cultures and the device length was increased 5 fold. Axonal 
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fraction was mainly collected by shear forces: rapid perfusion by micropipette causes 
disruption of axons by huge shear forces. The device design was further modified into a 
three chamber design to study mitochondrial transport in healthy and injured axons and 
integrated with automated tracking system. Shi et al. [99] developed a high-throughput 
microfluidic platform, synapse microarray for ultra-sensitive, large scale assays and 
quantitative screening of synaptic proteins involved in synaptogenesis. The synapse array 
design consists of two compartments one each for soma and axon connected by 
microchannels to isolate axons from soma. Axonal compartment is covered by a PDMS 
membrane (80 µm thick) with a clearance of 3 µm, providing no hindrance to axonal 
outgrowth. The purpose of this membrane is to contain genetically modified cells 
expressing synaptic membrane proteins in microwells defined in the membrane. Cells so 
contained in these microwells are evenly spaced out at defined densities and maintain good 
contact with axons to induce protein synthesis relevant to synaptogenesis in axons. This 
platform is a powerful tool to study molecules involved in synaptogenesis in a high-
throughput fashion with great degree of control in experimental parameters. Taylor et al. 
[100] developed a multicompartment microfluidic platform for visualization, 
manipulation, and biochemical analysis of synapses. The device design consists of three 
parallel chambers, two peripheral chambers for distinct neuronal populations and a middle 
chamber for perfusion. The two peripheral chambers are connected to the middle perfusion 
chamber with microchannels of unequal lengths. This unequal lengths in the design permits 
formation of functional, oriented, and unidirectional synapses between the two populations 
of neurons. The perfusion chamber has three inlets with the two peripheral inlets are for 
fluidic focusing. This fluidic focusing allows for precise collection of either presynaptic or 
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synaptic or post synaptic fractions for biochemical analysis. This device offers collection 
of fractions with a great order of spatiotemporal precision for synaptogenesis analysis.  
 
 
Fig 2.3: 1a. A schematic of the local perfusion chamber with three-inlet wells, 1b. Stable 
microenvironments with perfusion, 1c. Labeled neuron following perfusion (adapted from [100] 
copyright 2010 Elsevier), 2a. Schematic for micropatterning of PLL strip on a substrate and its integration 
with a compartmentalized microfluidic neuron culture device, 2b. Neurons transfected differentially in 
different compartments (adapted from [96] copyright 2012 American Chemical Society), and 3a. 
Schematic of the fabrication of synapse microarray, 3b Synapsin clustering in microwells with HEK293 
cells, and 3c. Enlarged view of the box (adapted from [99] copyright 2011 Nature Publishing Group) 
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2.3.3 Multi-compartment Chamber devices for Co-Culture  
Vertebrate nervous system is made up of several types of cells: neurons, astrocytes, 
oligodendrocytes, microglia in CNS, and neurons, Schwann cell in PNS. To effectively 
study the organization of nervous system, apart from studying individual populations one 
needs to study the interactions between several types of cells that make up the system. It is 
the only way to elucidate the emergent properties of the system which consists of paracrine 
signaling, action potential conduction, and pathologies associated with several 
neurodegenerative diseases like Multiple Sclerosis, Alzheimer’s, Parkinson’s etc. Nervous 
system also exchanges information with several other physiological systems in the body of 
an organism which makes it imperative to study the interactions between different types of 
cells. Typically, a cell co-culture platform should be able to (1) incorporate cells of various 
types in distinct regions, (2) self-sustain and provide optimal culture conditions, (3) 
selectively address, manipulate, and maintain each cell type without influencing the rest, 
(4) and control cell-cell interactions. Microfluidic platforms have the potential to meet all 
these requirements and several groups have taken up this aspect of microfluidics in co-
culture studies for neuroscience. 
 
Park et al. [103] developed a multi-compartment microfluidic platform for co-
culture studies of neurons and glia. The device design consists of an inner circular 
compartment for cell body isolation and an outer concentric circular array of 6 axonal 
compartments that are interspaced evenly at 400 µm. Each axonal compartment is 
connected to the central cell body reservoir by high fluidic resistance microchannels. They 
developed Micro-macro Hybrid Soft-lithography Master fabrication (MMHSM) technique 
36 
 
to enable the co-existence of both microscale and macroscale structures in single PDMS 
master molds. They studied parallel and localized biomolecular treatment capability of the 
device and myelination of axons by oligodendrocyte progenitor cells. Majumdar et al. [59] 
developed a microfluidic platform for neuron-glia co-culture which incorporates a valve, 
that when compressed enables complete isolation between the two types of cells acting as 
a physical barrier unlike in other devices where the fluidic isolation is achieved by 
hydrostatic pressure difference. In this device, the incorporation of valve completely 
eliminates interactions of any kind, even the smallest diffusions that may occur in 
hydrostatic fluidic isolation. The device design consists of two chambers one each for each 
cell type: neurons, and glia which are connected by microchannels and completely isolated 
by a pneumatically controlled valve. Gao et al. [60] further modified the device to mimic 
3D cell culture system by using gels sandwiched between the two sides of a modified valve. 
Takeuchi et al. [58] assembled a multielectrode-array with a microfluidic platform to co-
culture cells from different systems: neurological and cardiovascular. Their device enables 




2.3.4 Multi-compartment Chamber device for Injury, Regeneration, and 
Degeneration  
Focal or multifocal abuse to the axons in the white matter tracts of Central Nervous 
System (CNS) during Traumatic Brain Injury (TBI) and or Spinal Cord Injury (SCI) leads 
to Traumatic Axonal Injury (TAI). These injuries often lead to irreversible damage 
Fig 2.4: A. Schematic of the co-culture device for sympathetic neurons and cardiomyocytes, 1b SCG 
neurons in left compartment and 1c. Ventricular myocytes in the right compartment (adapted from [58] 
with permission from The Royal Society of Chemistry), 2a. Schematic of the multi-compartment neuron–
glia co-culture microsystem capable of carrying out multiple localized axon treatments in parallel, 2b, 2c 
& 2d. Depict axon glia co-culture separated by microchannels, and 2e. Depicts the reproducibility (adapted 
from [103] with permission from The Royal Society of Chemistry), 3a & 3b. Schematic of device that 
allows co-culture and separation with valves, 3c & 3d. Neurons in adjacent compartments transfected with 
different vectors (adapted from [59] copyright Elsevier 2010). 
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resulting in permanent loss of function. Modeling studies help to understand the biological 
mechanisms of nerve regeneration and degeneration and play a role in developing new 
therapeutic strategies. There are several modes of experimental setups: in vivo, in vitro, 
and in silico models to study injury. In vivo animal models of trauma permit the study of 
whole organism’s response to a multitude of complex variables and permit behavioral 
outcome studies. Though these models are useful, they are highly complex, of low 
reproducibility, involve large number of parameters, labor intensive, need specific skills, 
very time consuming, and most important of all, in vivo models lack tools to monitor events 
post injury and axonal regeneration in real time. In vitro models on the other hand allow 
the study of biochemical pathways, gene expression levels, and phenotypic changes to the 
level of a single axon. In vitro models also facilitate the study of different types of traumatic 
injuries like transection, compression, stretch, and shear[104].  
 
Microfluidics provide a powerful alternative to the existing in vivo and in vitro 
methods to model and study the axon injuries. They provide platforms: to model and study 
at single cell resolutions, that can be automated, with scope for multiplexing and high 
throughput[14]. Broadly classified, the modes of inducing injuries in neurons on these 
platforms are: (1) Physical, (2) and Chemical. Physical modes include employing laser 
ablation techniques [26-28], valve based compression of axons[61], microsurgeries and 
axotomy, are amongst the several to name. On the other hand chemical injuries are mostly 




Taylor et al. [106] pioneered in developing a multicompartment microfluidic 
platform to study CNS axon injury, regeneration and transport. The device design consists 
of two identical compartments physically separated by microchannels. Using this device 
platform they successfully isolated CNS axonal mRNA, and studied somal transcription 
activity in response to axotomy by vacuum aspiration in axonal compartment. Hellman et 
al. [107] developed a microfluidic platform integrated with picosecond lasers to study 
axonal injury and regeneration. Microdluidic injury platform combines MIMIC for surface 
patterning: alternating strips of Chondroitin Sulfate Proteoglycans (CSPG) and poly-L-
lysine were laid. The platform enables study of events after a partial or complete transection 
of axon. Kim et al. [108] developed a neuro-optical microfluidic platform integrating 
femtos second laser with microfluidic platform to study single axon injury and 
regeneration. The device model resembles that of Taylor et al. [106] with longer channels 
up to 5 mm in length. Yang et al. [25] developed a compartmentalized open chamber 




2.3.5 Multi-compartment Chamber device for Electrical Stimulation and 
Recording 
Neuronal organization as complex circuits and networks involve communication 
between neurons via chemical signaling. To determine the state and activity of a circuit or 
network one could either track the real time metabolic activity of each and every neuron 
involved or monitor fluctuations of the extra cellular field potential in the vicinity of the 
Fig 2.5: 1a. Microfluidic-based culture platform with illustrations of laser induced axotomy, 1b. Axotomy 
of 25 µm axon strips with 180 ps laser pulse (adapted from [107] with permission from The Royal Society 
of Chemistry). 2a. Schematic of the microfluidic device to study chemical injury, 2b & 2c. Chemical 
influenced degradation of axons with axonal side application of the chemical (adapted from [25] 
copyright Elsevier 2009), 3a & 3b. Schematic of the microfluidic culture platform for 
compartmentalization and fluidic isolation of axons from cell body (adapted from [106] copyright Nature 
Publishing Group 2005)  
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neurons involved. In a reductionist approach, one is more interested in the activity of a 
single neuron and ion channels involved. Based on the scale that the neurons operate, LOC 
offers great potential for developing novel platforms to record as well as stimulate activity 
in individual neurons. Kathryn et al. [109] developed soft material based PDMS electrode 
arrays to measure activity in individual neurons. These microfabricated soft electrodes are 
highly reproducible and allow high-resistance seal with cell membranes. Ravula et al. [110] 
microfabricated compartmented culture system to study neurons by established fluidic 
isolation. The axon were guided by tracks of collagen on glass substrate containing multi 
electrode arrays. This platform allows studying the effects of drugs on neurons with 
compartmentalization and selectively observe the electrical activity. Peterman et al [111] 
developed the artificial synapse chip, a high-resolution physiological retinal interface 
which incorporates MEMS techniques of micro-patterning of cells, and localized chemical 
stimulations with flexible and biocompatible materials. The incorporation of MEMS 
techniques in developing potential retinal interfaces is an advancement that is welcome in 
addressing issues with exiting interfaces. MEMS can be used for stimulating retinal cells 




2.3.6 Multi-compartment Chamber devices from our group 
2.3.6.1 Circular Compartmentalized co-culture device for axon-glial interactions 
A circular compartmentalized LOC platform was developed in the lab to co-culture 
neurons with glial cells and study axon-glia interactions[24]. The rationale behind 
developing such a platform is that several neuroinflammatory and neurodegenerative 
Fig 2.6: 1a. Schematic of integrated compartmented culture system, with microfluidic barriers and 
microelectrode array interfacing with cultured neurons. The multicompartment divider is aligned to and 
seated on the microelectrode array. Neurons are then plated in one or more of the compartments, after 
which they grow into adjacent compartments. Stimulation and recording electrodes on the microelectrode 
array interface with somal bundles and their processes in all of the compartments, allowing for 
complicated studies in which both neuronal pharmacology and electrophysiology can be simultaneously 
studied. (Adapted from [110] copyright Elsevier 2006), 1b. Conceptual sketches of the Artificial Synapse 
Chip. With an illustration of a single stimulation site and a multiple pixel device shown interfacing the 
retina. (Adapted from [111] copyright John Wiley and Sons 2003) 
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diseases strongly imply specific interactions between axons and glia [112, 113]. Then 
existing culture techniques did not support precise placement of cells and control of cell 
body and axonal microenvironments; this device is developed to address these issues. The 
developed LOC platform has two concentric arrays of multiple independent compartments 
which are interconnected by several microchannels between the inner circular and outer 
circular compartments in a one on one mapping. The circular geometry of the device allows 
for ready merging of adjacent compartments allowing to maintain independent cell bodies 
or axons in either distinct of uniform microenvironments. The circular geometry of the 
device also enables the enhancement of axonal output through microchannels by 
centrifugation. It also enables use of patterned microstencils to directly place glial cells 





Fig 2.7: 3D schematic of the PDMS device with compartments and microchannels in the side to aid 





Poly-D-lysine (PDL) (100 μg ml-1, Sigma) 
Sodium tetraborate, (99%, 100 g, Sigma) 
Boric acid, (99.5%, 100 g, Sigma) 
PDMS (Sylgard 184, Dow Corning) 
Neurobasal media (Invitrogen) 
Disposable plastic weigh boats for mixing PDMS 
Disposable plastic stir rods  
40 mm glass bottom petri dishes (Willco Wells, Netherlands) 
Razor blades 
Sharpened stainless steel punch 
Transparency mask (CAD/Art service) 
Photoresists, SU-8 2002 and SU-8 3050 (Microchem) 
SU-8 photoresist developer (Microchem) 
4 inch silicon wafer (WRS Materials, CA) 
EQUIPMENT 
Digital balance 
Laboratory oven for curing PDMS 
Vacuum desiccator for degassing PDMS 






Neuron culture media: Neurobasal media. 
Borate buffer solution: Prepare 0.1Mborate buffer solution (1.24 g boric acid, 1.9 g sodium 
tetraborate, 400 ml Nanopure water, pH 8.5). 
PDL solution: Dissolve 400mg of PDL (1 mg ml-1) in borate buffer solution by stirring for 
30 min. Sterilize the solution by filtration with 0.2 mm filter. PDL solution can be stored 
at -20 oC for future use. 
PROCEDURE 
Fabrication of master template TIMING 9 h 
1. Dehydration Bake: Clean a 4-inch Si wafer with compressed N2 gas and place it on a 
hot plate set at 200 oC for 10 minutes for dehydration bake. (If the relative humidity is 
>10% you may have to increase the duration of the bake.) 
2. Plasma treatment: Plasma treat the dehydrated Si wafer with O2 plasma at 350 mtorr 
pressure and 250 W power for 3 minutes to clean the wafer surface and improve surface 
roughness for better adhesion to photoresist. 
3. Photo resist coating: Flood SU-8 2002 photoresist on a plasma treated 4-inch Si wafer 
and spin at 1,000 rpm for 30 s (2.5-3 μm thick). 
4. Soft bake: Bake the photo resist coated wafer for 2 min at 95 oC on a leveled hot plate. 
5. Exposure: Expose the soft baked wafer through a high-resolution transparency mask 
(20,000 dpi, CAD/Art, OR) containing a circular array of 1500 microchannels of width 
8-10 μm and length 500 μm evenly spaced at 15-25 μm at 100 mJ/cm2. 
6. Post exposure bake: After exposure, bake the wafer at 95 oC for 4 min on a hot plate. 
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7. Development: Develop with SU-8 developer (photoresist developer) by spraying the 
developer on the wafer until all of the unexposed photoresist is stripped off. 
8. Rinse with isopropyl alcohol two or three times to check the development, if it leaves 
white streaks on the wafer use the developer again. 
9. Spin dry the wafer to remove excess developer and or isopropyl alcohol. 
10. Heat the developed wafer on hot plate at 95 oC for 10 min to remove any residual fluid 
to improve adhesion for the second layer of photo resist on wafer. 
11. Photo resist coating: Spin a second layer of photoresist, SU-8 3050, at 1,000 rpm for 
30 s (150 μm thick). 
12. Soft bake: Bake the second layer of photo resist for 45 min at 95 oC on a leveled hot 
plate. 
13. Mask alignment: Align a high-resolution transparency mask (CAD/Art, OR) containing 
an outer circular array of axon ports (4 mm in diameter) and an inner circular array of 
soma ports (3 mm in diameter) with the alignment cues on the soft baked wafer from 
the first layer of photoresist.  
14. Exposure: Expose the soft baked wafer through the aligned high-resolution 
transparency mask for the second layer at 250 mJ/cm2. 
15. Post exposure bake: After exposure, bake the wafer at 95 oC for 5 min on a hot plate. 
16. Development: Develop with SU-8 developer (photoresist developer) by spraying the 
developer on the wafer until all of the unexposed photoresist is stripped off. 
17. Rinse with isopropyl alcohol two or three times to check the development, if it leaves 
white streaks on the wafer use the developer again. 
18. Spin dry the wafer to remove excess developer and or isopropyl alcohol. 
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19. Hard bake: Bake the wafer at 150 oC on a hot plate at least for 6 hours. 
 
Fabrication of PDMS devices by replica molding TIMING 4 h 
20. Weigh out a 10:1 ratio (50 g + 5 g) of PDMS base to cross-linker into a disposable 
weigh boat and mix thoroughly for 5–10 min. 
CRITICAL STEP: If PDMS is not mixed thoroughly or the amount of catalyst is not 
adequate, PDMS will not cure completely and will make the master mold unusable. 
21. Place the PDMS mixture in a vacuum desiccator and degas the bubbles formed during 
mixing for 30-60 min. 
22. Passivate the Si wafer by silane treatment for 10 – 15 min (usually longer, 45-60 min 
during first use). 
23. Place the master template wafer in a plastic weigh boat and while gently pressing on it 
with a Q-tip slowly pour the PDMS mixture over it to achieve a thickness of 5-7 mm. 
Let the PDMS spread out and settle evenly for 10 min. If there are any bubbles in the 
region of interests pop them with sterile pipette tips or a clean razor blade. 
24. Place the weigh boat in a leveled laboratory oven and cure for 60 min at 80 oC. The 
PDMS mixture will solidify and become transparent when fully cross-linked or cured. 
25. Cut the plastic weigh boat to remove the cured PDMS mold with master. Carefully 
remove the PDMS mold from the master wafer applying gentle pressure in order to not 
to break the wafer. 




27. Punch out the somal ports using 3 mm biopsy punches and punch out the axonal ports 
using 4 mm biopsy punches with the channel side up. Clean both the surfaces by using 
a Scotch tape to remove any debris resulted during the excision. 
28. Further sonicate the cleaned devices in 100% ethanol for 5 min with feature side down 
to remove any residual debris. Once sonicated, clean the devices with compressed air 
to remove PDMS debris and other surface contaminants. 
 
Cleaning the glass bottoms and bonding with the devices TIMING 30 min 
29. Sonicate the 40 mm glass bottom petri dishes in 100% ethanol for 5 min with the 
bonding side down. Once sonicated, clean the glass bottoms with compressed air to 
remove surface contaminants. 
CRITICAL STEP Debris removal on both the bonding surfaces is paramount for a leak 
free and tight seal. Small particles resulting during punching can act as barriers when 
bonding PDMS to glass substrate.  
30. For a reversible seal bring into contact the cleaned devices (with features side down) 
and cleaned glassed bottoms which seal reversibly upon contact. 
31. For a tighter seal, treat both the device and the glass bottom surfaces with oxygen 
plasma at 45 W for 1 min and bring into contact the feature side surface of the device 
to the glass bottom and gently press on the device against the glass bottom for a tight 
seal.  
CRITICAL STEP: When sealing the PDMS to substrate, do not press around the channels 




Coating the assembled devices with PDL TIMING 13-14 h 
32. Sterilize the devices with 70% ethanol and wash the device thrice with doubly 
deionized water to remove excess ethanol under a sterile laminar hood. 
33. Coat the devices with PDL by adding PDL only to one of the two ports of the device 
and let the PDL flow. Once the PDL flow is established, top both the ports with PDL 
and set the devices aside for overnight coating at 37 oC in a humidified incubator. 
CRITICAL STEP Make sure that no air bubbles are tapped to ensure uniform coating of 
PDL. 
34. Remove the PDL from all the ports and wash off excess PDL in 3 rinses with doubly 
deionized water.  
35. Add the Neurobasal media in the ports and store the device at 37 oC until needed for 
experimentation. 
Fig 2.8: The device mold was constructed using standard SU-8 photolithography. (A) Beginning with a 
bare silicon wafer, (B) an initial thin-film resist layer (SU-8 2002; height ¼ 2.5 mm) was spun, soft 
baked, and optically exposed. (C) Subsequently, the substrate was post exposure baked and immersed in 
developer to define the circular array of microchannels. (D & E) The thick-film resist (SU-8 3050; height 
¼ 150 mm) was processed similarly to define larger fluidic access ports. After (F) PDMS replication, 
(G) devices were customized through the use of commercially available dermal biopsy punch tools. 
(Reproduced from [16] with permission from The Royal Society of Chemistry) 
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The circular compartmentalized microfluidic neuron culture device offers a novel 
method to integrate large access ports in close proximity to (a) microchannels providing 
straightforward loading of cells near microchannels, (b) increase the cell density near the 
entrance of microchannels with optimized platform geometry so that centrifugal forces can 
be quickly applied to manipulate neuronal cell distribution, (c) manipulate co-culture 
conditions using micropatterning techniques, (d) study axon micro glial interactions, (e) 
study differential microglial response to injured axons, and (f) establish hydrostatic 
pressure to achieve fluidic isolation. The other advantages that the circular geometry of the 
device confers is that the external forces required to enhance cell placement at the end of 
the microchannels are minimal which has a direct implication in maximizing the cell 
viability and perpetuating axon-glial co-culture. This microfluidic device can serve as an 
in vitro model for CNS injury. We utilized this platform to demonstrate preferential 
accumulation of microglia specifically to injure as compared to healthy axons, serving as 
a foundation to elucidate mechanisms of axon–glia interactions in neurological disease 
maintenance and progression. Overall, this novel multi-compartment co-culture platform 
enables distinct modes of axon–glia co-culture and provides experimental versatility to 
investigate axon-specific and axon–glia-specific cellular and molecular events implicated 
in neurobiological disease. 
 
2.3.6.2 Circular Compartmentalized device for microglial phagocytosis of axons 
A novel circular compartmentalized LOC platform was developed in the lab to co-
culture neurons with microglial cells to investigate mechanisms of microglial phagocytosis 
of bundled axons [114]. The rationale behind developing such a platform is that the 
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persistence of endogenous debris in mammalian CNS is one of the foremost barriers to 
regeneration after injury [115, 116]. A critical insight into the microglial debris clearance 
mechanism in CNS opens new avenues for CNS repair strategies. Then existing culture 
techniques did not support precise placement of microglia and control of cell body and 
axonal microenvironments. The current device is developed to address these issues. The 
developed LOC platform uses an extra cellular matrix (ECM) patterning device to create 
25 μm wide tracks of PDL for the axons to grow along and bundle in a circular 
arrangement. These tracks are evenly spaced with a gap of 25 μm in between them 
facilitating the attachment of microglia. Once the ECM tracks are laid a similar circular 
LOC device with microchannels is aligned on the tracks. The ECM patterning facilitates 
that the axon bundles remain spatially distinct and localized from microglia once emerging 




Poly-D-lysine (PDL) (200 μg ml-1, Sigma) 
Sodium tetraborate, (99%, 100 g, Sigma) 
Boric acid, (99.5%, 100 g, Sigma) 
PDMS (Sylgard 184, Dow Corning) 
Neurobasal media (Invitrogen) 
Disposable plastic weigh boats for mixing PDMS 
Disposable plastic stir rods  




Sharpened stainless steel punch 
Transparency mask (CAD/Art service) 
Photoresists, SU-8 2002 and SU-8 3050 (Microchem) 
SU-8 photoresist developer (Microchem) 
4 inch silicon wafer (WRS Materials, CA) 
EQUIPMENT 
Digital balance 
Laboratory oven for curing PDMS 
Vacuum desiccator for degassing PDMS 
Plasma cleaner (Harrick Plasma, NY) 
REAGENT SETUP 
Neuron culture media: Neurobasal media. 
Borate buffer solution: Prepare 0.1Mborate buffer solution (1.24 g boric acid, 1.9 g sodium 
tetraborate, 400 ml Nanopure water, pH 8.5). 
PDL solution: Dissolve 400mg of PDL (1 mg ml-1) in borate buffer solution by stirring for 
30 min. Sterilize the solution by filtration with 0.2 mm filter. PDL solution can be stored 
at -20 oC for future use. 
PROCEDURE 
Fabrication of master template TIMING 9 h 
a. The master template of ECM patterning device consists of only one layer of photoresist 
defining the height of channels for ECM tracks. The fabrication of which is similar to 
the one described in the previous section in following steps: 1-10 & 19. 
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b. The master template for the co-culture device consists of two layers of photoresist 
defining the height of channels and the height of chambers. The fabrication of which is 
similar to the one described in previous section in following steps: 1-19  
   
Fabrication of PDMS devices by replica molding TIMING 4 h 
a. Fabrication of ECM patterning device by replica molding is similar to the one described 
in the previous section in following steps: 20-28 
b. Fabrication of co-culture device by replica molding is similar to the one described in 
the previous section in following steps: 20-28 
 
Cleaning the glass bottoms and bonding with the devices TIMING 30 min 
1. Sonicate the 40 mm glass bottom petri dishes in 100% ethanol for 5 min with the 
bonding side down. Once sonicated the glass bottoms are cleaned with compressed air 
to remove surface contaminants. 
CRITICAL STEP Debris removal on both the bonding surfaces is paramount for a leak 
free and tight seal. Small particles resulting during punching can act as barriers when 
bonding PDMS to glass substrate. 
2. For a reversible seal bring into contact the cleaned devices (with features side down) 
and cleaned glassed bottoms which seal reversibly upon contact. 
3. For a tighter seal, treat both the device and the glass bottom surfaces with oxygen 
plasma at 45 W for 1 min and bring into contact the feature side surface of the device 




CRITICAL STEP: When sealing the PDMS to substrate, do not press around the channels 
region, as they can collapse and may be blocked when excessive pressure is applied. 
 
Coating the assembled devices with PDL TIMING 13-14 h 
4. Sterilize the devices with 70% ethanol and wash the device thrice with doubly 
deionized water to remove excess ethanol under a sterile laminar hood. 
5. Coat the devices with PDL by adding PDL only to one of the two ports of the device 
and let the PDL flow. Once the PDL flow is established, top all the ports with PDL and 
set the devices aside for overnight coating at 37 oC in a humidified incubator. 
CRITICAL STEP Make sure that no air bubbles are tapped to ensure uniform coating of 
PDL. 
6. Remove the PDL from both the ports and wash off excess PDL in 3 rinses with doubly 
deionized water.  





The circular compartmentalized microfluidic neuron culture device offers novel 
methods to integrate large access ports in close proximity to (a) microchannels providing 
straightforward loading of cells near microchannels, (b) increase the cell density near the 
entrance of microchannels with optimized platform geometry so that centrifugal forces can 
be quickly applied to manipulate neuronal cell distribution, (c) manipulate co-culture 
conditions using micropatterning techniques, (d) study axon micro glial interactions, (e) 
study differential microglial response to injured axons, and (f) establish hydrostatic 
pressure to achieve fluidic isolation. The other advantages that the circular geometry of the 
device confers is that the external forces required to enhance cell placement at the end of 
Fig 2.9: Microfluidic platform enables the study of microglial phagocytosis of axons. Ai, A patterning 
process was used to create 25 µm-wide PDL stripes interspersed by 25 µm gaps. Aii, The microfluidic 
coculture device was aligned and bonded. Aiii, Aiv, Neurons cultured within the cell body compartment 
extended axon bundles through the microchannels and into the axon/glial coculture compartment (Aiii) 
where microglia were later cocultured (Aiv).B. The microfluidic platform was modified by creation of a 
third compartment. Before addition of wild type or TRIF knock out mouse microglia, a scalpel was used 




the microchannels are minimal which has a direct implication in maximizing the cell 
viability and perpetuating axon-glial co-culture. This microfluidic device can serve as an 
in vitro model for CNS injury. Hosmane et al. [114] utilized this platform to demonstrate 
preferential accumulation of microglia specifically to injure as compared to healthy axons, 
serving as a foundation to elucidate mechanisms of axon–glia interactions in neurological 
disease maintenance and progression. Overall, this novel multi-compartment co-culture 
platform enables distinct modes of axon–glia co-culture and provides experimental 
versatility to investigate axon-specific and axon–glia-specific cellular and molecular 
events implicated in neurobiological disease. 
 
2.3.6.3 Valve based multi compartmental device for Traumatic Axonal Injuries 
A novel microfluidic compression platform called axon injury micro-compression 
(AIM) platform to study traumatic axonal injuries (TAI) at single axonal resolution was 
developed in the lab [61]. The active component in inflicting a focal and graded injury to 
a single axon is a compressible valve that can be pushed down on to the axons with varying 
forces. This device when combined with time-lapse microscopy allows monitoring the fate 
of axons during the time course of an injury. Existing devices had shortcomings in 
delivering focal and graded compression injuries to the axons, and studying the time course 
of injury [117]. The device design consists of two layers: (1) fluid layer, that contacts glass 
substrate, and (2) control layer, that defines compression and subsequent deflection of 
valve by fluid. Fluid layer in contact with the glass substrate defines three distinct 
compartments: (1) cell body, (2) injury, and (3) axonal. This compartmentalization enable 
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the study of TAI independent from cell bodies and the injured axons can be subject to 




Poly-D-lysine (PDL) (200 μg ml-1, Sigma) 
Sodium tetraborate, (99%, 100 g, Sigma) 
Boric acid, (99.5%, 100 g, Sigma) 
PDMS (Sylgard 184, Dow Corning) 
Neurobasal media (Invitrogen) 
Disposable plastic weigh boats for mixing PDMS 
Disposable plastic stir rods  
Fig 2.10: Schematic of AIM platform with master template on the left and PDMS device on the rice 
(adapted from [61] with permission from The Royal Society of Chemistry). 
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40 mm glass bottom petri dishes (Willco Wells, Netherlands) 
Razor blades 
Sharpened stainless steel punch 
Transparency mask (CAD/Art service) 
Photoresists, SU-8 3005, SU-8 3025, and SU-8 3050 (Microchem) 
SU-8 photoresist developer (Microchem) 
4 inch silicon wafer (WRS Materials, CA) 
EQUIPMENT 
Digital balance 
Laboratory oven for curing PDMS 
Vacuum desiccator for degassing PDMS 
Spin coater 
Plasma cleaner (Harrick Plasma, NY) 
REAGENT SETUP 
Neuron culture media: Neurobasal media. 
Borate buffer solution: Prepare 0.1Mborate buffer solution (1.24 g boric acid, 1.9 g sodium 
tetraborate, 400 ml Nanopure water, pH 8.5). 
PDL solution: Dissolve 400mg of PDL (1 mg ml-1) in borate buffer solution by stirring for 
30 min. Sterilize the solution by filtration with 0.2 mm filter. PDL solution can be stored 
at -20 oC for future use. 
PROCEDURE 
Fabrication of master template TIMING 9 h 
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c. The master template of AIM device consists of three layers of photoresist defining the 
height of channels, clearance for the injury pad, and the chambers respectively. The 
fabrication of which is similar to the one described in the previous section in following 
steps: 1-18 for the first two layers and then 10-19 for the third layer. 
Fabrication of PDMS devices by replica molding TIMING 4 h 
1. Weigh out a 10:1 ratio of PDMS base to cross-linker into a disposable weigh boat and 
mix thoroughly for 5–10 min. 50 g + 5 g for control layer, and 10 g + 1 g flow layer.  
CRITICAL STEP: If PDMS is not mixed thoroughly or the amount of catalyst is 
not adequate, PDMS will not cure completely and will make the master mold 
unusable. 
2. Place the PDMS mixture in a vacuum dessicator and degass the bubbles formed during 
mixing for 30-60 min. 
3. Passivate the Si wafers (control layer and flow layer) by silane treatment for 10 – 15 
min (usually longer, 45-60 min during first use). 
4. For the control layer, place the master template wafer in a plastic weigh boat and while 
gently pressing on it with a Q-tip slowly pour the PDMS mixture over it to achieve a 
thickness of 5-7 mm. Let the PDMS spread out and settle evenly for 10 min. If there 
are any bubbles in the region of interests pop them with sterile pipette tips or a clean 
razor blade. 
For the flow layer, place the master template on a spin coater and hold it in place under 
vacuum. Pour the PDMS over the wafer so that atleast ¼ of the wafer is covered and spin 
at 800 rpm for 1.5 min. 
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5. Place the weigh boats in a leveled laboratory oven and cure for 20 min at 80 oC. The 
PDMS mixture will solidify and become transparent when fully crosslinked or cured. 
CRITICAL STEP The PDMS cross-linking should be controlled in a careful manner to 
establish good bonding between control and flow layer. The curing step should neither be 
too long nor too short. The PDMS should be lightly sticky but not tacky.  
6. Cut the plastic weigh boat to remove the cured PDMS control mold and master. 
Carefully remove the PDMS control mold from the master wafer applying gentle 
pressure in order to not to break the wafer. Punch the gas inlets with sharpened gauge 
# 23 needles in each device and punch out the devices from the mold. Clean the bonding 
surface with scotch tape to remove debris from punching. 
7. Plasma treat both the flow layer and punched control layer devices at 45 W power for 
1 min. Align the control layer devices to flow layer with the help of cues on both the 
layers. Once aligned cure the bonded device at 80 oC overnight in the incubator.  
8. Excise the devices form flow layer master template and punch ports using 3 mm biopsy 
punches. Clean both the surfaces by using a Scotch tape to remove any debris resulted 
during the excision and punching. 
9. Further sonicate the cleaned devices in 100% ethanol for 5 min with feature side down 
to remove any residual debris. Once sonicated clean the devices with compressed air 
to remove PDMS debris and other surface contaminants. 
Cleaning the glass bottoms and bonding with the devices TIMING 30 min 
10. Sonicate the 40 mm glass bottom petri dishes in 100% ethanol for 5 min with the 
bonding side down. Once sonicated, clean the glass bottoms with compressed air to 
remove surface contaminants. 
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CRITICAL STEP Debris removal on both the bonding surfaces is paramount for a leak 
free, and tight seal. Small particles resulting during punching can act as barriers when 
bonding PDMS to glass substrate.  
11. For a reversible seal bring into contact the cleaned devices (with features side down) 
and cleaned glassed bottoms which seal reversibly upon contact. 
12. For a tighter seal, treat both the device and the glass bottom surfaces with oxygen 
plasma at 45 W for 1 min and bring into contact the feature side surface of the device 
to the glass bottom and gently press on the device against the glass bottom for a tight 
seal.  
CRITICAL STEP: When sealing the PDMS to substrate, do not press around the channel 
region, as they can collapse and may be blocked when excessive pressure is applied. 
Coating the assembled devices with PDL TIMING 13-14 h 
13. Sterilize the devices with 70% ethanol and wash the device thrice with doubly 
deionized water to remove excess ethanol under a sterile laminar hood. 
14. Coat the devices with PDL by adding PDL first to one of the two injury ports followed 
by cell body port and distal port on the same side of the device and let the PDL flow. 
Once the PDL flow is established, top all the ports with PDL and set the devices aside 
for overnight coating at 37 oC in a humidified incubator. 
CRITICAL STEP Make sure that no air bubbles are tapped to ensure uniform coating of 
PDL. 
15. Remove the PDL from all the ports and wash off excess PDL in 3 rinses with doubly 
deionized water.  
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16. Add the Neurobasal media in the ports and store the device at 37 oC until needed for 
experimentation. 
 
With the AIM platform we could successfully establish injury thresholds for 
different axon responses in primary rat embryonic CNS cells and this is for the first time 
that a valve structure was used to injure axons in a microfluidic setting. This AIM platform 
can also be extended to study the secondary injury aspects in a traumatic axonal injury, like 
cytoskeletal changes, transport disruption, calcium fluctuations, mictochondrial fate etc. 
The advantages with this platform is that single axons can be isolated and a focal graded 
injury can be delivered in a controlled way. The time course of injured axon can be easily 
tracked for its fate which further enables one to conduct drug screening studies. 
 
2.4 Discussions & Future Directions 
Several practical issues as delineated earlier with in vivo systems in the study of 
neuroscience prompts one to adopt in vitro approaches. To reiterate, traditional in vitro 
approaches to neuroscience has its own limitations like: (1) Simulating varying 
extracellular microenvironment along the length of neurons, (2) Independent and 
interference free study of axons which has  implications in neurodegenerative diseases, 
injuries, axonal damage , isolation of the axonal biomolecules,  axonal transport studies, 
and (3) Co-culture studies of neurons with various cell types. To address these limitations 
MEMS and microfluidics are being extensively employed. Though the concept of MEMS 
was developed in the 70’s, initially intended for chemical analysis, the presence in biology 
and subsequently neuroscience is being felt in the last decade. This primarily is due to the 
63 
 
fact that integration of MEMS technology with biology needed development of technology 
in its infancy to a state where it can address the complex needs of biological systems in 
parallel to the biology and neuroscience itself. People started realizing the potential in 
MEMS and developed several LOC devices for neuroscience ranging from injury studies, 
electrophysiology, co-culture, synaptogenesis, learning and memory, disease and 
therapeutic strategies etc. 
 
Though being applied in a wide spectrum of neurobiological studies, MEMS 
technology is still in its early developmental phase. Majority of the existing LOC platforms 
are 2D systems restricting the study to a plane, and because of this current studies are 
limited to dissociated and organotypic cultures. In their native state, the organization of 
tissues and organs is 3D and neurons are no exception. Cellular organization at tissue and 
organ scale is non homogenous and it implies a necessity for co-culture studies. Though 
there are LOC platforms currently available for co-culture studies they are not sophisticated 
enough to perform network level studies. With the advancement in technology these may 
soon be addressed. 
 
The future of LOC devices for neuroscience can be envisioned as highly modular, 
versatile, and programmable on similar scales of semi-conductor industry. The first 
generation of computers occupied huge spaces and performed limited tasks. Current 
generation of computers are small enough to be carried in pockets and perform a multitude 
of tasks simultaneousl. On a similar note, it is not exaggerating when one imagines a future 
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of MEMS and LOC devices with highly customizable and modular units which can be 
programmed to a wide and highly specific array of needs in neuroscience. Also the wide 
spread use of LOC platforms will enable their commercialization and use in day to day 




A compartmentalized culture platform to study axon 
regeneration and localized effects of GDNF 
 
3.1 Introduction 
Use of compartmentalized cell culture devices for neuroscience is commonplace 
nowadays. Conceptualized and realized as Campenot chamber in late 1970’s, it is the 
earliest attempt at maintaining compartmentalized neuronal cell cultures. The Campenot 
chamber was used to isolate axons from neuronal cell bodies in studying the role of 
retrograde transport of neurotrophic factors in neuronal cell survival [118].  Owing to 
limitations like low efficiency & throughput, and cumbersome fabrication & maintenance 
of silicone grease barrier led to the replacement of Campenot chamber with better 
alternatives like bioMEMS and LOC devices. MEMS technology is being explored 
extensively for biological applications, part of which deals with neuronal cultures to 
separate somal and axonal compartments with precise control. MEMS technology being 
used in fabrication of LOC devices involves soft lithography for replica molding. 
Polydimethylsilosane (PDMS) is the material widely chosen for several physical properties 
which render it useful for neuronal culture purposes both in CNS and PNS neurons [24, 25, 
119]. These LOC devices have two isolated chambers physically interconnected by array 
of parallel microchannels. This setup enables fluidic isolation between the two chambers 
by establishing hydrostatic pressure differences which is maintained over extended periods 
of time due to high resistance of microchannles [120, 121].  Once the cells are seeded, the 
66 
 
proximity to the channels determines the fate of neurons to extend axons through 
microchannels, and application of hydrostatic pressure difference across microchannels 
induces fluidic isolation between axon and neuronal cell body allowing a researcher to 
manipulate each cellular compartment independently of each other. Despite the potential 
for fluidic isolation in LOC devices, no critical appraisal of separation of soluble factors 
has been carried out. 
 
The purpose of this study is twofold: 1) to examine the critical parameters of 
microfluidic device that facilitates stable fluidic separation of somal and axonal 
compartments over extended periods time, and 2) to examine the site of action of three 
neurotrophic factors in an in vitro axotomy model of sensory axonal regeneration. We 
chose to use three members of the Glial cell line-derived neurotrophic factor (GDNF) 
family of neurotrophic factors which are previously known to play important roles in neural 
development and various neurological diseases [122-127]. In particular, they have been 
shown to promote survival and differentiation of dopaminergic neurons, motor neurons 
and dorsal root ganglion (DRG) sensory neurons [128-131]. Due to its therapeutic 
potential, a number of studies have evaluated the role of GDNF in the nervous system in 
the setting of disease and traumatic injury [132-134]. In addition to GDNF, other members 
include neurturin, neublastin, and persephin [135]. In clinical trials and animal 
experiments, GDNF has been shown to enhance myelination [136-138] and enhance 
survival of motor neurons in models of amyotrophic lateral sclerosis [139-141], and 
dopaminergic neurons in models of Parkinson’s disease [142, 143]. Similarly, neurturin 
showed increased survival of motor and dopaminergic neurons [144-146] and neublastin 
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was effective in reducing neuropathic pain [147-149]. In addition, all members of the 
GDNF family showed enhancement of axon outgrowth after axotomy [150-152]. However, 
the biological site of action of GDNF family members in axon regeneration is not well 
characterized. Traditional in vitro settings for neuronal cultures do not facilitate 
compartmentalization of axons from neuronal cell bodies, thus making it difficult to 
delineate axon-specific mechanisms.  Using the compartmentalized microfluidic chamber 
system we examined the parameters critical to diffusion of neurotrophic factors between 
the chambers and tested the regenerative potential of GDNF, neurturin and neublastin. 
Similar to previous publications, GDNF was most potent but its potency was most 
noticeable when the neurotrophic factor was applied to the neuronal cell bodies directly. 
To examine if the regrowth enhancement effect with axon application of GDNF was real, 
we applied a retrograde transport blocker, Cytochalasin D, concurrently with GDNF. We 
demonstrated that this effect is lowered in the presence of a transport blocker, indicating 
that GDNF may need to be transported to the cell body or systemically in order to see 
optimum growth. These results help to further elucidate GDNF’s role in regeneration 
following injury as well allow for further factors for consideration in its potential use as a 
therapeutic treatment. 
 
3.2 Materials and Methods 
3.2.1 Cell preparation  
All experiments involving animals were conducted according to protocols 
approved by the Animal Care and Use Committee of the Johns Hopkins University School 
of Medicine. Unless otherwise noted, tissue culture supplies were obtained from Invitrogen 
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(Carlsbed, CA). Dorsal root ganglia (DRG) neuronal cultures were prepared as previously 
described [136]. Briefly, DRGs were dissected from decapitated embryonic age day 15 
rats. Once obtained, cells were enzymatically dissociated with 0.25% Trypsin in L15 
medium and then suspended in media. The DRGs were maintained in Neurobasal medium 
containing 10% fetal bovine serum, 20% glucose, 1 % penicillin/streptomycin, B-27 
supplement, 2 M L-glutamine, and 10 ng/ml glial derived nerve growth factor (GDNF). 
Two days after seeding cells, neurobasal media containing 10 μM of Cytosine arabinoside 
was added to the cultures in order to decrease the amount of glial cells. 
 
3.2.2 Compartmentalized microfluidic platform (CMP) preparation  
A two-step photolithographic process was utilized to create the master mold. 
Silicon wafers (University Wafer, MA) were coated with SU-8 2002 (Microchem; MA), 
spun, and soft baked using parameters specified by the manufacturer to yield a resist 
thickness of 2.5 µm. An array of microchannels, each with dimensions: width = 10 µm, 
length = 500 µm, were defined by UV light exposure through a high resolution DPI 
transparency (Cad/Art, OR). The exposed substrate was once again baked, to enhance 
polymer cross-linking post exposure, and developed as stated in the resist technical sheet 
to fully define the microchannels. The process was immediately repeated with SU-8 3050 
(Microchem; MA) to define the fluidic reservoirs with dimensions: width = 3 mm, length 
= 13 mm. The master mold was then treated with trichlorosilane (United Chemical 
Technologies; PA) for 30 minutes to create a nonstick surface for subsequent processing. 
Standard soft lithography was performed using Sylgard 184 polydimethylsiloxane (PDMS) 
(Dow Corning, MI) as described previously (Ng, et al., 2003). After curing, the PDMS was 
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carefully removed from the master and access ports were created using a suite of dermal 
biopsy punch tools (8 mm) (Huot Instruments, WI).   
 
3.2.3 Cell loading  
DRG neurons were loaded into the soma side of devices and grown for 5 days to 
allow axons sufficient time to grow through channels and into the axonal side. Using a 
glass pipette, axons were transected at the base of the microchannels and neurotrophic 
factors were applied to axonal or neuronal cell body compartments at a concentration of 
100 ng/ml, a commonly used peak concentration for various neurotrophic factors.  
Regeneration of axons was monitored by daily imaging of the axonal side and measuring 
the length of longest axon coming from each microchannel. A minimum of 10 axons per 
experimental condition was measured and experiments were done in triplicates. 
 
3.3 Results  
3.3.1 Theoretical Profile of Growth Factor Diffusion  
In order to identify whether growth factors can diffuse from the axonal to cell body 
compartment during the treatment of growth factors in the axonal compartment, we 
developed models to simulate this experimental setup. The central idea behind the 
compartmentalized platform is to have fluidic connectivity between microchannel-
connected compartments. If the microchannels contain a small cross-sectional area (< 
30μm2), this device paradigm allows axons to grow from one compartment into another 
but attenuates the diffusion of molecules from the compartment of lower hydrostatic 
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pressure to the compartment of higher. In our experiment a small differential pressure 
gradient was established with a higher pressure in the axonal compartment as compared to 
the cell body compartment. As a result, a low velocity retrograde flow was created in the 
microchannels to prevent molecular anterograde diffusion. We show theoretically, through 
computational simulations, that chemical isolations are achieved when working with the 








Fig. 3.1: Formulation of the diffusion advection problem. 
 
The diffusion of any molecule in a fluid medium is governed by the diffusion-
convection equation. The first term including spatial derivatives of concentration describes 
passive diffusion while the second term including the velocity of the medium describes 








Where  C is the concentration at a point (x,y,z) at time t 
D is the coefficient of diffusion  
x = 0 x = L 
velocity u 
C = CL C = C0 
x  





 is the velocity vector at the point (x,y,z) at time t 
The pressure and concentration gradients driving the dynamics are mainly along the groove 
(x-axis) and hence, this can be approximated as a one-dimensional problem. Steady state 










Where u is the x-component of the velocity 























Where Δh is the height difference of water column at inlet and outlet (leading to the 
pressure difference which drives the flow), ρ is the density and η is the viscosity of water 
(saline) and a is the channel height (the most critical dimension for laminar flow). 
Due to the geometry of the system,  
Δh is limited to about 2mm,  
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a is 2.5μm (height of the groove) 
The other constants used are  
g=9.81m/s2,  
η= 0.00089 m2/s 
ρ= 1000 kg/m3 
 
The diffusion coefficient D is calculated indirectly from its inverse dependence on 
the square root of molecular weight of the diffusing species. Doxygen is known to be 2x10
-9 








Table 3.1 shows a list of the growth factors we used along with their molecular weights and the calculated 
diffusion coefficients. 






Human GDNF 21 kDa [153] 5.5x10-11 m2/s 
Rat Neurturin 19.5 kDa [145] 5.7x10-11 m2/s 
Rat Neublastin 4.5 kDa [154] 1.2x10-10 m2/s 
 
It suffices to work with a mol. wt. of 4.5 kDa as it is the smallest molecule we use, 
with the highest tendencies to diffuse. Or, stated otherwise, the amount of growth factor 
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diffusing to the somatic compartment will also be less than the amount of rat neublastin 


















Thus, there is negligible diffusion from the axonal compartment to the somatic 
compartment at steady state. Care must be taken that while doing the experiments, the 
height difference in the two compartments must be achieved before adding the growth 
factor to the axonal compartment so that there is always an anterograde flow preventing 
diffusion of species in the retrograde direction. 
 
3.3.2 Computational Simulations to Study Diffusion Patterns of Growth Factors 
Simulations were done in COMSOL Multiphysics (Formerly called FEMLAB; 
COMSOL Inc., MA), a finite element-modeling package. The complex nature of the 
geometry was simplified to study the diffusion pattern in only one of the microchannel 
grooves. Each microchannel has a plane of symmetry passing through the middle (a plane 
going from floor to ceiling all along the length halfway between the two vertical walls). 
Further simplification of the geometry was done using such symmetric considerations and 
only half a microchannel needed to be simulated (Figure. 3.2a). Simulation consisted of 
meshing the architecture into a grid of smaller elements. The aspect ratio of such finite 
elements was tailored to suit the aspect ratio of the microchannel, that is, elements were 
longer along the length (x-axis) than along the width or height (y and z axes respectively). 
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The geometry was first solved for fluidic parameters such as velocity and pressures at all 
points. This was done by solving the continuity and Navier-Stokes equations for the 
microchannel. While all three cases were simulated as described above, we present the 
results of rat neublastin (the smallest molecule we used) diffusion (figure 3.2b). This 
suffices to demonstrate the paucity of small molecule diffusion through a microchannel 
feature. 
 
3.3.3 Restriction of diffusing analytes 
Fluid volumes were modified such that the somal compartment was of lower fluidic 
height than the axonal compartment. By doing so, a hydrostatic pressure was established 
between these microchannel-connected compartments, thereby creating a small flow to 
counteract diffusive forces. A 1 microliter bolus of fluorescein isothiocyanate (FITC; 
Sigma, MO) dye was introduced to the somal compartment and was imaged over the course 
Fig 3.2: a. Handling of the groove geometry for computational simulations. Half the groove is meshed 
for computational solutions of fluid dynamics and diffusion-convection equations. P plot showing the 
concentration drop along the groove from the axonal side (right side) to the somatic side (left side). The 
profile along the middle of the groove shows the profile along one of the edges of the groove, b. 
Computational simulation of diffusion profile of growth factor along microchannel groove. Plot shows 
the concentration drop along the groove from the axonal side (right side) to the somatic side (left side) 
within 100 μm of the 500 μm channel. The profile along the middle of the groove shows the profile along 
one of the edges of the groove. 
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of 24 hrs. Empirically, a fluid height difference ≥ 2 mm was sufficient to prevent the 
diffusion of a low-molecular weight (MW 700 Da) analyte to the axonal compartment for 
at least 24 hrs (Figure 3.3). Continued maintenance of the height differential by adding 5 
microliters of media to the higher volume compartment daily allowed for restriction of 
small analytes.  
 
3.3.4 Axotomy and axonal regeneration by neurotrophic factors  
In order to identify the regrowth of axotomized axons, we allowed neuronal 
processes to grow into the axonal chamber and then transected axons using a glass pipette 
or metal syringe. The representative figure (figure 3.4) to visualize single axons, before 
and after axotomy in a case where the seeding density is low. We observed some retraction 
Fig 3.3: Analyte restriction maintained for 24 hrs. Di↵usion of a small (MW 700) fluorescent analytes 
were examined under high hydrostatic pressures. Microchannels (region between dashed lines) connect 
compartments of unequal fluid height. Establishment of fluid heights >2 mm prevented entry of dye 
(solid white lines) into the compartment of higher fluid height. Scale bar 100 μm. 
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and degeneration of axons when they are cut slightly farther from the microchannel 
opening.  
 
Then, we added recombinant GDNF, neublastin, or neurturin to either axon or cell 
body compartments of cultured DRG neurons for 72hours. Multiple images of the axons 
were captured using phase contrast microscopy and we used ImageJ (NIH; Bethesda, MD) 




to calculate percent changes in axon lengths before and after axotomy in the presence or 
absence of growth factors. In figure. 3.5, we see representative images of the DRGs before 
and after different neurotrophic factor treatments, all taken at the same magnification. In 
these images, we see the axons exiting channels and traversing into the axonal 
compartment on the right. 
 
As summarized in figure 3.6, all of the neurotrophic factors induced enhanced 
axonal regeneration whether they were applied to the axonal or somal compartments but 
GDNF was most potent. Furthermore, there was a slight benefit to applying GDNF to the 
somal compartment. In order to determine if the enhancement effect of adding GDNF to 
the axonal compartment was real, we carried out experiments with concurrent application 
of GDNF and Cytochalasin D. In figure 3.7, we cans see that the results indicate that this 
enhancement is diminished with the application of retrograde transport blocker, indicating 




Fig 3.5: Representative phase contrast images of regenerating axons where neurotrophic factors were 


























Axon growth rate (micron/hrs)
Fig 3.6: Axonal regeneration by GDNF, neurturin (NT) and neublastin (NB) after the axotomy. Rate of 
axonal regeneration induced by the neurotrophic factors over 3 days. (p < 0.05) 
Fig 3.7: Axon regeneration with axonal GDNF application compared with axonal GDNF 




Compartmentalized microfluidic culture systems have been utilized in a variety of 
neuronal studies, from examining the effects of toxins and neuroprotectants on axons 
versus soma, to enhancing spatial and temporal control of neurons and other cultures, and 
performing axon-glia co-culture studies [25, 155-157]. Several injury systems have been 
incorporated within microfluidic culture devices in order to investigate axon-specific 
mechanisms in injury and regeneration. These systems include simple aspiration of the 
distal compartment, two-photon laser ablation, and hydrodynamic shear based axotomy 
[158, 159]. In the current study, through modification of the device into an open system, 
we were able to transect axons simply and easily by scratching the surface of the glass with 
a sharp glass pipette or metal syringe.  
 
As compartmentalized microfluidic culture devices have become ubiquitous, 
appropriate characterization of the diffusion properties within the devices would not only 
be beneficial but necessary. This study demonstrates a potential pitfall in designing and 
carrying out microfluidic experiments with neuronal cultures. Unless a proper hydrostatic 
pressure is maintained, there is no true fluidic separation of the axonal and neuronal cell 
body compartments. Experiments studying the effects of individual local manipulations of 
axons and neuronal cell bodies will have to take these observations into consideration. This 
is especially true for small molecular manipulations as they are more likely to diffuse 




Neurotrophins have traditionally been known to play integral roles in neuronal 
survival during development, but only relatively recently has their function in regeneration 
been explored. [160] GDNF and its family of growth factors, neurturin, artemin, and 
persephin, represent a class of novel neurotrophic factors. These growth factors signal 
through a two-receptor complex consisting of rearranged during transfection (RET) Trk 
and a glycosylphosphatidylinositol (GPI)-linked GFR-α. The growth factors GDNF, 
neurturin, artemin, and persephin preferentially bind to bind to GFR-α1, GFR-α2, GFR-
α3, and GFR-α4, respectively. GDNF has been shown to provide neuroprotection and 
promote axonal regeneration, but the role of the other family members is not as clear.  
 
Injury to peripheral nerve reactivates its intrinsic growth capacity, and the 
retrograde transport of injury signals has been suggested to be one of the essential 
mechanisms for regeneration [161]. The retrograde transport of GDNF has been postulated 
to act as a positive injury signal for induction of regeneration.[162] The enhancement of 
regeneration by GDNF within our in vitro system is consistent with previous studies. It has 
previously been demonstrated that GDNF selectively promotes regeneration of injury 
primed sensory neurons, both in vitro where GDNF caused enhancement of neurite 
outgrowth in preconditioned DRG neurons, and in vivo where GDNF administered directly 
to cell bodies in lesioned spinal cord facilitated the preconditioning effect and enhanced 






In our study we found that GDNF acts as a more potent inducer of regeneration 
than the other GDNF family growth factors (neurturin, neublastin) which we examined. 
GDNF and its receptor GFR-α1 are upregulated in the distal denervated segment of injured 
nerve, suggesting that GDNF may provide trophic support for injured peripheral neurons. 
No analogous upregulation of neurturin, persephin, and artemin or their receptors was 
found following injury [164]. However, it is note-worthy that we do see enhancement of 
regeneration at all if this is the case.  
 
The finding that GDNF administered to cell bodies produced better results than 
GDNF administered to distal axonal compartments is interesting which further led to 
explore the role of retrograde axonal transport/relay of GDNF signal to cell body which 
maybe a reason for the observation. A previous study utilized compartmentalized cell 
culture devices to study the role of GDNF as a retrograde survival factor and its ability to 
promote survival over long distances to cell bodies [165]. In this study, it was found that 
GDNF promoted survival of DRG neurons equally well from either distal axon or cell body 
application. However, this study was not done within an injury model, and the DRG 
neurons were relatively healthy, and thus the reason for this discrepancy in the potency of 
GDNF depending on location of application may be due to the fact that we are using injured 
DRG neurons. It is important to note that the mechanism of action of GDNF may be 
different in these two systems, indicating the need to study the role of growth factors in 
both injury and developmental systems separately. It has been demonstrated that GDNF 
and GFR-α1 are retrogradely transported in peripheral axons, but these studies were also 
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done in relatively healthy neurons.[166] Axonal injury may have an impact on protein 
turnover and retrograde transport, and this may impair some of the retrograde pathways for 
GDNF transport, making the application of GDNF directly to the cell bodies more 
effective. Our experiments comparing axonal GDNF application alone and together with 
Cytochalasin D demonstrate the important role of retrograde transport of GDNF as well as 
indicate that the enhanced regeneration effect may be cell body specific rather than at the 
localized axon.  
 
Neurotrophic factors are a promising area of research for understanding 
regeneration. Their role in providing trophic support during development and in 
maintenance of neurons has long been known, but elucidating their roles in regeneration 
may prove fruitful in the development of therapies for overcoming neural degeneration and 
for enhancing regeneration post injury. Understanding axon specific or cell body specific 
effects of growth factors and being able to distinguish between local effects and retrograde 
signaling will be necessary for any future therapies. Compartmentalized microfluidic 
culture devices may be instrumental in these studies, but caution must be exercised to better 





A Novel 3-Dimensional In Vitro Platform to Study 
Focal and Repetitive Axonal Injury 
4.1 3D AIM platform 
4.1.1 Introduction 
Traumatic injuries and insults in various modes to Central Nervous System (CNS) 
often transgress as Traumatic Axonal Injuries (TAI). TAI involve focal to multi-focal 
damage of axons within the white matter tracts of the brain, and based on the degree and 
extent of TAI, the effects are often debilitating with a complete loss of function [167]. The 
functional restoration is greatly limited by the fact that CNS environment is not conducive 
of axonal regeneration [168, 169]. In spite of the gravity of TAI, many mechanistic details 
involved remain unknown and the individuals who suffer mild to medium brain injuries 
continue their activities only to succumb to devastating compounded injuries far worse 
than each of their isolated insults.  
 
Primary insult to axons in TAI leads to secondary insults which might be even more 
severe and degenerative than the primary alone. The primary insult can be of various forms: 
mechanical forces arising from stretch, compression, shear or in combination of any of 
these lead to secondary insults. Secondary insults involve changes at morphological and 
biomolecular scales: disruption of cytoskeleton, axonal transport, axonal protein synthesis, 
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mitochondrial structural changes [170-173]. Recent evidence suggests that mild axonal 
trauma, on the other hand, may cause subtle axonal injury that is often reversible.  
However, long-lasting changes may become encoded within the axon- a form of traumatic 
“memory”- rendering the axon far more vulnerable to future traumatic insults predisposing 
them to a more severe secondary insult. Therefore, it is of critical importance to understand 
the mechanisms and consequences of focal axon injury and to correlate injury with the 
degree and nature of forces exerted upon the axon.  
 
The modeling and study of complex dynamics involved in the settings of traumatic 
injuries in CNS and PNS provide valuable mechanistic insights about these injuries that 
are often irreversible resulting in permanent loss of function. The modeling studies help 
understand the biological destiny of injured nerves and axons, regeneration or degeneration 
and play a role in developing new therapeutic strategies. There are several experimental 
setups like in vivo, in vitro, and in silico models to study the injury [1, 26-28, 35]. In vivo 
animal models of trauma enable the study of whole organism’s response to a multitude of 
complex variables and even facilitating behavioral studies. In vivo models encompass 
Instant rotational injury model, Impact acceleration injury model, Lateral fluid percussion 
injury model, Controlled cortical impact model, Nerve stretch model, complete transaction 
model, and complete contusion model [1, 174]. Though in vivo models are useful, they do 
not permit study at single cell resolution, highly complex to operate, low reproducibility, 
large number of parameters to model, labor intensive, need specific set of skills, and are 
very time consuming. Also, they are limited by technological advancements to study time 
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course of degeneration following an injury, response to graded injuries, and changes in 
biochemical pathways along the time course of an injury challenging. 
 
In vitro models, on the other hand, allow the study of biochemical pathways, gene 
expression levels, and phenotypic changes at single axon resolutions. In vitro models also 
facilitate the study of different types of traumatic injuries like transection, compression, 
stretch, and shear [1, 35, 174]. Microfluidics provides a powerful alternative to the existing 
in vivo and in vitro methods to model and study the axon injuries. They provide platforms: 
to model and study at single cell resolutions, compartmentalization and precise control over 
cellular microenvironments, can be automated, require little amount of reagents, scope for 
multiplexing and high throughput [49, 175, 176]. Several kinds of microfluidic devices are 
developed for the applications in neuroscience as these devices’ settings can be broadly 
employed for neuron cell culture, neuron manipulation, neural stem cell differentiation, 
neuropharmacology, neuro-electrophysiology and neuron biosensors. [11-13, 21, 53, 177]. 
 
Development of microfluidic platforms for neuronal studies is propelled by 
following limitations to traditional in vivo and in vitro studies: (1) like in the case of in 
vivo, compartmentalization of the axon from soma is absent. A detailed investigation of 
sub-cellular events during injury isolated to either axons or soma is desired and hence the 
distinction between axon-specific and cell body-specific events; (2) lack of accuracy and 
precision in delivering spatiotemporally controlled injury to axons; (3) lack of high 
resolution imaging modality pre, during, and post axonal injury, and (4) lack of a tools to 
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measure the magnitude of various forces acting on axons during the injury.  The issue of 
compartmentalization to study axons independent from cell body in peripheral nervous 
system (PNS) is first addressed by developing the Campenot chamber in 70s [3]. This 
chamber uses Teflon partition on a glass petri dish which divides and creates fluidic 
isolation between three chambers by the application of silicon grease. However, Campenot 
chamber is not suitable for CNS applications as the CNS neurons are far smaller in size, 
the reproducibility of silicon grease seal between glass and Teflon is low, and is very 
laborious. To circumvent these existing issues with traditional platforms in several lab-on-
chip (LOC) approaches emerged to the study CNS neuronal cultures [10, 11, 97, 119, 175, 
176, 178-180]  
 
One of key the aspects of TAI is focal and graded axonal injury [117, 167], and 
LOC platforms to study focal and graded TAI in CNS axons were developed [61, 107, 
108]. Hosmane  et al. [61] developed an axonal injury micro-compression (AIM) platform 
with active valve components created from deformable biocompatible elastomeric 
material, poly (dimethylsiloxane) (PDMS). This platform integrates microfluidic valve 
technology with compartmentalization of CNS axons from their neuronal cell bodies. By 
pushing down the valve on an axon segment, a focal and graded compressive injury can be 
imparted. The study revealed a trimodal response to the graded injuries. Though the study 
elucidated new aspects of injury dynamics they do not precisely mimic in vitro conditions: 
(1) axons were subject to injury on a glass substrate which is of several order magnitude 
stiffer compared to biological tissues, and (2) does not combine the study of compression 
and stretch based injuries which are more likely to happen, in combination. 
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Motivated by this, I developed an add-on to the already existing AIM platform to 
substitute the glass substrate with a soft gel substrate whose material stiffness can be tuned. 
The combined novel microfluidic platform allows observation of focal and graded 
mechanical injury to CNS axons as a combination of compression and stretch. Fabrication 
of microfluidic platforms to allow a focal, graded mechanical injury to isolated CNS axons 
in a manner compatible with high resolution optical microscopy and spatiotemporal 
tracking. The developed platform potentially allows: (1) incorporation of a methacrylated 
gelatin gel substrate to allow complex injury modalities mimicking in vivo injury models 
to single CNS axons, (2) development of finite element models to characterize the 
mechanical load applied to the axons during injury setting, (3) experimental identification 
of stress thresholds for modal responses both in the settings of reversible and irreversible 
axonal injuries, and (4) determine sub-cellular spatiotemporal fluctuations of Ca2+ flux and 
cytoskeletal rearrangements at the site of injury, an early indicator of injury severity. 
4.1.2 Materials and Methods 
4.1.2.1 Fabrication of the master template and molds 
The third layer of the assembled device, the substrate layer of AIM device was 
fabricated in PDMS. The master template for the substrate layer was created using single 
layer photolithography process. 4 inch silicon wafers (University Wafer, MA) were spin 
coated with 150 µm thick SU-8 3050 (Microchem, MA) and exposed to UV radiation with 
transparency mask (CAD/Art, OR) to define 4 parallel chambers (figure 4.1) for gel 
substrates. Each of these four chambers runs along the width of three parallel compartments 
in the AIM device. Once the master template is fabricated, substrate layer molds were 
prepared in PDMS. PDMS pre-polymer was mixed in 5:1 ratio (w/w) of base to curing 
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agent so that excess cross-linker results in better bonding with the second (fluid) layer of 
AIM platform. Secondly, the stiffness of the mold can be increased such that a thin, strong 
layer of it could be created to fit the entire 3 layered assembly in a petri dish without any 
contact with the lid there by avoiding potential contaminations. 
 
 
4.1.2.2 Fabrication of the gel substrate and establishment of the gradient 
Methacrylated gelatin gel is a photo-crosslinked hydrogel that is biocompatible. 
Gelatin is chemically modified with the incorporation of methacrylate to amine groups in 
gelatin to form methacrylated gelatin. Methacrylated gelatin was synthesized as described 
previously [181]: Type A porcine skin gelatin was dissolved in Dulbecco’s phosphate 
buffered saline (DPBS) at 60 °C and methacrylic anhydrate was added to this solution in 
required ratio to control the degree of cross-linking. The solution was constantly stirred at 
50 °C and allowed to react for 1 h and lyophilized. Photoinitiator 2-hydroxy-1-(4-
(hydroxyethoxy)phenyl)-2-methyl-1-propanone (Irgacure 2959) was added to the 
Fig 4.1: Master template of ECM layer for the modified AIM platform. 
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macromer in 0.5% (w/v) DPBS. The dissolved solution was injected into the ECM mold 
channels using a pipette and crosslinked via strong UV irradiation for 2 min. 
 
Linear diffusible gradients of glial cell-derived neurotrophic factor (GDNF) were 
generated in methacrylated gelatin hydrogels that were established in channels using a 
surface tension driven, single channel microfluidics gradient generation method previously 
described in [182]. Methacrylated gelatin hydrogels were established in the channels of the 
ECM device and FITC-GDNF in DPBS was placed at the output of the channel as a drop. 
A smaller (in volume) drop of FITC-GDNF was placed at the input. Due to the surface 
tension a forward flow is established and a gradient is created. 
 
4.1.2.3 Assembly of modified device 
Methacrylated gelatin gels were established in the ECM devices using a plain a 
PDMS block for planar surface. The devices were peeled off from the PDMS block and 
cleaned carefully with scotch tape. AIM device fabricated using the method described in 
[61] was plasma treated and was placed on top of the ECM device, aligned and 
bonded.zThe whole assembly was placed in a 30 mm glass bottom petri dish and subjected 







4.1.2.4 Cell Preparation and loading 
Devices were coated with 200 µg ml-1 PDL (Sigma, MO) as an extra cellular matrix 
(ECM) layer prior to cell seeding. The devices were left overnight at 37 oC, washed 3X 
next day with ddH2O, and filled with neuro basal/B27 [24] media and stored in standard 
humidified incubator (Thermo Scientific, MA) at 37 oC with 5% CO2 until used. Rat 
embryonic day 17 (E17) primary hippocampal neurons were derived as previously 
mentioned in [183] and used for this studies. E17 cells derived were seeded at low densities 




4.1.3.1 Establishment of stable soluble gradients in gels in ECM devices 
ECM layer design of the device incorporates establishment of stable and soluble 
gradients of neurotrophic factors in the methacrylated gelatin gels. The dimensions for each 
of the 4 lanes for gels (one for each injury pad) are chosen such that the cell bodies are not 
exposed to chemical cues in the gels. In doing so, we could essentially study the 




regeneration of axons post injury solely under the influence of growth cone’s response to 
cues in the proximal part of axon. 
 
Methacrylated gelatin solution was first loaded in the channels and cross-linked 
with UV irradiation to form gels in the lanes. Once the gels were formed from cross-linking 
a concentrated drop of fluorescently-labelled GDNF was introduced at the input ports. Due 
to surface tension and capillary action a gradient of GDNF is established in the channels 
(figure 4.3). The initial bump in the concentration of GDNF is due to the fact that there is 
a sudden increase in the cross section between the input ports and the lanes. This step 
change in cross section leads to dead zones at the corners where there is no CGDNF and 




Fig 4.3: a) Fluorescently-labeled GDNF gradients generated simultaneously in four separate channels 
(channels are arranged from top to bottom). b) Quantification of gradients in the four channels 
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4.1.3.2 Compatibility between hydrogels and cells  
Before cultures could be established in the modified platforms the compatibility of 
rat E17 1o hippocampal cells with methacrylated gelatin gels has to be checked. Hence, 
methacrylated gelating gels were established in 96 well culture plates and the gel surfaces 
were modified with various conditions to investigate the compatibility. The gels were 
treated with the conditions mentioned in table 4.1. Inspection of cells under microscope 
right after and an hour into seeding revealed considerable aggregation, an indicator of poor 
health and compatibility of cells with methacrylated gelatin gels. The gels were then doped 
with other ECMs like collagen, laminin, and fibronectin to improve the compatibility with. 
To verify that the ECM coating is proper on the gels, fluorescently-labelled PLL (FITC-
PLL) was used (figure 4.4). Though FITC-PLL revealed proper coating on gels inside the 
wells, no improvement in compatibility was observed. Methacrylate group being acidic, 
we suspected the presence of any uncross-linked residue from synthesis of methacrylated 
gelatin could decrease the pH of hydrogel. Accordingly the gels were washed with either 
HBBS or DPBS 3x times before further ECM coating. All these modifications were futile 
and seemed not to improve the compatibility between methacrylated hydrogels and cells. 




Concentration of dopants 
(µg ml-1) 
Notes 
1 Mgelatin + PDL 25, 50, 75, 100, 200 
Media turns 
yellow 
2 Mgelating + Collagen 0.5 
Media turns 
yellow 
3 Mgelatin + Fibronectin 0.5 
Media turns 
yellow 
4 Mgelatin + Laminin 0.5 
Media turns 
yellow 












4.1.3.3 Cultures in the modified injury platforms 
ECM layers were aligned and assembled with the AIM devices to form a single 3D 
TAI compressive injury platform. Methacrylated gels in ECM layer were often not planar 
and this resulted in failure of fluidic isolation between chambers of AIM device. This can 
be due surface tension forces in the hydrogels resulting from rehydration with media. 
Nevertheless, to estimate the initial performance of the device rat E17 1o hippocampal cells 
were used. As seen in the figure, due to the lack of fluidic isolation cell could be seen in 
all the compartments. Also, gels were not compatible to the cells and the cells started 
aggregating as early as 20 min post seeding in the devices. Mice dissociated DRG neurons 
were used instead of rat E17 1o hippocampal cells to check whether they can be limited to 
Fig 4.4: a) Clumping of cells on methacrylated gelatin doped with fibronectin and coated with FITC-PLL 
on day 2, b) clumping of cells on methacrylated gelatin doped with laminin and coated with FITC-PLL 
on day 2, c) clumping of cells on methacrylated gelatin doped with both fibronectin and laminin and 
coated with FITC-PLL on day 2, d) control, e) clumping of cells on methacrylated gelatin washed with 
HBBS and coated with FITC-PLL on day 2, and f) cells on methacrylated gelatin doped with collagen 
and treated with HBBS and coated with FITC-PLL on day 2 (scale bar 50 microns) 
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the cell body chamber due to their size in spite of the lack of fluidic isolation. To eliminate 
the chances of cell dispersion in all chambers cells were seeded directly on top of the gels 
instead of conventional loading through the cell loading ports. Though the DRGs extended 
their axons and remained healthy (figure 4.5), these results could not be reproduced. 
 
4.1.4 Discussions 
TAI occurring in the settings of traumatic brain injury and spinal cord injury can 
be result of insults of various kinds. Amongst those various modes of insults compression 
is one. TAI resulting from compression injury was earlier established and studied in giant 
squid axons. Giant squid axons are rendered easy to handle because of their large size (>0.5 
mm in diameter). Initial experiments with these axons gave insights into the compression 
injuries in axons but these studies cannot shed light on the mechanical characteristics of 
CNS cells. Also, CNS axons are very small in comparison to giant squid axons and very 
delicate to handle with. 
Fig 4.5: a) Dissociated DRG cells seeded in the modified AIM devices can be seen under the channels 
on methacrylated hydrogels due to the loss of fluidic isolation resulting from the concavity of hydrogel 
surface, b) healthy DRG cells with no aggregation in the cell body chamber of AIM devices 10 days in 
culture. (scale bar 50 microns) 
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In order to study compression injury in CNS axons, each axon should be addressed 
individually to track down the post injury cellular sequences. To achieve this techniques 
should be developed to handle each axon independently. Existing techniques like laser 
ablation achieves the job but they are qualitative, they do not present information about the 
stress being directly applied to the axon. It is important to study the stress directly being 
applied to an axon because based on the degree of strain the injury outcome and cellular 
response changes. Current TAI platform is intended to address the issue of obtaining 
quantitative information from the insults to axons. 
 
TAI platform is a LOC device that incorporates MEMS and soft lithography 
technologies to mold a device in PDMS. To quantitatively study the stress on axon the 
device incorporated a valve that deflects under a pressure which can be controlled. Using 
this device previous study found out that axons have a trimodal response post injury based 
on the input pressure to the valve. Though this outcome gave new insights into the extents 
of axonal regeneration after injury the study did not reflect the physiological conditions 
which may be different from what has been observed. In order to improve the device and 
make it closer to mimic physiological conditions the hard glass substrate is exchanged with 
soft ECM layer. 
 
An ECM layer was developed as add on to the existing TAI platform to replace the 
current hard glass substrate with a soft ECM layer molded in PDMS. For ECM 
methacrylated gelatin gels were chosen as the stiffness of the gel can be fine-tuned based 
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on the cross linker in the pre polymer mixture. The whole assembly doesn’t modify design 
and mechanism of TAI platform which eliminates the optimizations usually involved with 
new designs. Though the TAI platform is kept intact the ECM layer has to be optimized.  
Developed ECM layer has optimization issues that are to be worked out before any further 
experiments. First and foremost the compatibility of the gels with rat primary E17 
hippocampal cells has be improved. Currently the gels are acidic as can be seen when 
neurobasal media is added to the gels. The pH indicator turns yellow indicating that the pH 
of gels is acidic which maybe a reason for the incompatibility. Then there is the issue of 
the concavity of gel surfaces that disturb the fluidic isolation meant to be achieved by the 
microchannels. This could be altered by changing the surface tension of the gels or 
modifying gels such that they expand after cross-linking or rehydration to fill the gaps 
established between the gels and microchannels. Once these issues could be optimized the 
stiffness of gels can be varied and gradients can be established. By varying the gel stiffness 
one could study the post injury response of axons to varying stiffness in the gels. 
 
4.1.5 Conclusions 
This study aims at improving the physiological relevance of the TAI device by 
incorporating soft substrate for the axons to grow on and to be injured. This is a very simple 
modification to the existing device by adding a layer of PDMS to incorporate soft 
substrates under the channels. Rat dissociated DRG neurons were successfully cultured in 
the devices but could not be injured due to the lack of fluidic isolation. Rat 1o E17 
hippocampal cells survived on the gels only once amongst several trials. If the gels could 
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be made more compatible the device would give great insights into the post injury axonal 
response based on the stiffness of the substrate.  
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4.2 Displacement control device 
4.2.1 Introduction 
The dynamics of TAI are still elusive and not yet completely deciphered. In the 
settings of a TAI it is the secondary insult, an outcome of the primary injury which is more 
debilitating. The cytoskeletal disruption and reorganization due to these repeated 
secondary insults often do not present any observable symptoms. It has been widely 
accepted that changes to the cytoskeletal structure within axons are the primary means for 
axonal collapse following injury. Actin filaments, intermediate (neuro-) filaments, 
microtubules, and cross-linking proteins collectively are responsible for the structural 
properties of the neuronal axon. While the cytoskeletal network contribution has been 
accepted, the mechanisms by which this structure degrades and the contribution of each 
cytoskeletal components is not understood. Insight into the structural mechanics of these 
alterations will lead to a more complete comprehension of neural axon cellular integrity. 
 
Previous studies of axonal injury in the giant squid axon [184] have yielded 
generalized descriptions of morphological outcomes to graded mechanical loading 
resulting in distinct types of responses including continued maintenance, slow/fast 
retraction, and wallerian degeneration of the axon. The large size (> 1mm) of the giant 
squid axon permits physical manipulation of the tissue, however the far smaller sizes of 
mammalian CNS axons have precluded them from similar experimental manipulations. 
Therefore, to date, there has been little quantitative correlation between applied stress and 
the injury response of CNS axons. Apart from a recent study investigating the mechanical 
role of microtubules in stretch injury to the axon [185], previous studies have either focused 
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on stress application to the whole neuron, thereby masking axon-specific effects, or have 
looked at stress levels that induce complete axon transection [106]. 
 
Importantly, spatiotemporal tracking of cellular and sub-cellular changes in the 
axon has been one of the greatest challenges to understanding the primary and secondary 
injuries in the setting of traumatic insult to the CNS. Our aim is to develop a microfluidic 
platform by utilizing the previously established AIM platform technologies proposed in 
[61] with rigorous computational modeling, we could potentially achieve a fundamental 
understanding of the dynamics of a) axon morphology, b) calcium flux, and c) membrane 
and cytoskeletal rearrangements and “injury memory” as functions of graded compressive 
and tensile strain. In this study, we will seek to understand mechanisms by which forces 
causing mild reversible injury may lead to irreversible axonal damage when applied 
repetitively. We plan to achieve these by modifying the injury pad in AIM device by 
introducing notches along the length of the pad. The notches would permit the compression 
of axon to varying degrees based on the pre-defined clearance heights of the notches from 
the substrate from which the axons grow when compressed. 
 
4.2.2 Material and Methods 
4.2.2.1 Fabrication and assembly of injury platform 
The axon injury micro-compression (AIM) platform previously described in [61] is 
modified in the valve design to incorporate the notches. The earlier design was a three layer 
fabrication process and the current design incorporates an additional layer in between layer 
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2 and layer 3. This additional layer defines the notch clearance from the glass substrate 
below which is usually in sub-micron sizes. This new layer 3 was defined by using SU8 




4.2.3.1 Incorporation of the notch layer in master template 
Master template of the device is defined on a 4 inch silicon wafer in positive relief. 
The fabrication of the master template involves 4 layer photolithography process. The 
layers are stacked progressively on top of each other, and each layer is designed in such a 
way that the features of the layer above are projected onto the layer below along with its 
own features. While stacking the layers, the features on the layer that is being stacked are 
always confined within the area of the features defined below. This is to ensure that the 
features do not collapse during replica molding in PDMS. The first layer (bottom to top) 
defines the microchannels for axons, the second layer defines the clearance for the valve, 
the third later defines the height of the notches, and the final layer defines the height of 
compartments. 
 
Thickness of the third layer which defines the height of the notches is less than a 
micron and is at least 20 times less compared to other layers. This submicron thickness 
poses a challenge and the protocol has to be modified in defining this layer. Low viscosity 
of the photoresist and an inhomogeneous surface smoothness (due to the presence of 
exposed areas) results in improper distribution of photoresist during the spin coating of the 
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third layer. This results in the absence of well-defined features and in order to improve the 
adhesion between layer 2 and layer 3, layer 2 is subject to plasma treatment which increases 
surface roughness. Layer 2 is subject to plasma etching for 100 watts and 30 seconds at 
600 mtorr, higher pressure results in lesser etching of the surface. 
 
4.2.3.2 Finite Element Method (FEM) modeling and notch design 
The valve structure defined by Hosmane et.al.[61] was modified to incorporate 
discrete patterns of notches with predefined height clearance from the bottom of the glass 
Fig 4.6: a) On a bare silicon wafer, microchannels were defined in two linear arrays of microchannels, b) 
a second thicker resist is used to define the overall injury pad clearance, c) on top of this layer a submicron 
thick layer was coated to define the notch heights, d) finally on top of this the actual layer for injury pad 
is defined, e & f) depict the top view of the same. (Schematics are not to scale) 
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surface (figure 4.7). The clearance was introduced such that upon compression the axons 
traversing under the notches are subject to partial compression which will alter the fabric 
of cytoskeleton in the axon. The length of notches are defined as gaps and the spacing or 
interspersion between them as pedestals, which actually make the contact with glass 
substrate, when subject to pressure. Starting with an iteration of 200 µm gap and 80 µm 
pedestal lengths, devices were fabricated in PDMS and the valves were subject to 
compression under compressed CO2 gas. The integrity of the modified valve is 
compromised and it started collapsing under pressures 10-20% higher than the minimum 
required for a contact with the glass substrate. The loss of structural integrity in the valve 
defeats the purpose of having a control over the degree of compression of an isolated axon. 
Hence FEM was employed to model and define pedestal and gap lengths to modify the 
structural and mechanical integrity of valve in action. 
 
For FEM analysis, all the modeling parameters were borrowed from the model 
previously defined in [61]. FEM simulations with 200 µm gap length and 80 µm pedestal 
lengths resulted in buckling and collapse of pedestals at pressures as little as 7 psi (figure 
4.8). In order to find optimal gap and pedestal lengths FEM simulations were first run to 
check response at 7 psi and then the degenerate loading response at 55-95 kPa (table 4.2). 
A gap distance of 10 µm and a pedestal distance of 20 µm were found to be optimal with 
a 77 % clearance intact when a notch height of 910 nm was considered. Further FEM 
simulations were run to determine of range of notch heights for the devices. All the 
simulations were performed to study the degenerate loading response (applied load 55-95 
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kPa) at 10 psi. The simulations yielded a minimum height of 400 µm to work with and 
anything below it collapses (table 4.3). 
 
 
Fig 4.8: a) FEM analysis of modified compression pad of notch device under no compression with 200 
µm gap length and 80 µm pedestal length, b) zoomed version of the control condition, c) FEM analysis 
of modified compression pad of notch device under compression at 7 PSI, pressure needed to barely 
contact the glass substrate, d) zoomed in version of the compressed condition where one can clearly 
visualize the buckling 
Fig 4.7: a) Modified compression pads with addition of notches created by gaps of a defined height 
clearance from glass substrate, b) Modified flow layer master template for the fabrication of 
displacement control devices. 
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Table 4.2a FEM simulations to determine the gap length and pedestal length 
Gap length Pedestal length Displacement (µm) Clearance (µm) % Clearance 
10 10 0.21647 0.69353 76.2120879 
10 20 0.208609 0.701391 77.0759341 
10 40 0.212688 0.697312 76.6276923 
20 10 0.452194 0.457806 50.3083516 
20 20 0.423282 0.486718 53.4854945 
20 40 0.37877 0.53123 58.3769231 
40 10 0.91 0 0 
40 20 0.430553 0.479447 52.6864835 
40 40 0.823168 0.086832 9.54197802 
 
Table 4.2b. FEM simulations for degenerative loading for chosen gap and pedestal 
lengths 
psi Clearance (µm) % Clearance STDEV 
7 0.696668 76.5569 0.003569 
8 0.666726 73.2665 0.004040 
10 0.607234 66.7290 0.004954 
12 0.548264 60.2488 0.005831 
14 0.489809 53.8251 0.006674 
 
 
Degenerative loading response at 10 psi (applied load between 55-95kPa) indicated no collapse of the 
modified injury pad for a gap length of 10 µm and pedestal length of 20 µm indicating the choice of 
dimensions for modified injury pad. 
Note: Above simulations in table 4.2 a & b were done assuming a notch height of 910nm and the 
simulations are run at 7 psi, pressure needed to barely make the contact with glass substrate 
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4.2.3.3 Valve operation, stability, and notches 
As a proof of principle for sustained compression of axons in the device and to 
evaluate valve performance over extended periods of time we performed experiments using 
FITC conjugated PLL to pattern the gap zones on glass substrates. Devices in PDMS were 
fabricated from master molds with a notch clearance height of 500 nm. The devices were 
assembled, cleaned, plasma treated, and bonded to glass substrates. Bonded devices were 
filled immediately with molecular grade water and stored at 37 oC until used. The inlet 
ports for CO2 gas in control layer were set up and the modified valves were compressed. 
Once the contact with glass substrate was established, the water was exchanged with FITC-
PLL (10 µg/ml) in the chambers.  
 
Notch Height (nm) Clearance (µm) % Clearance STDEV 
100 0.000000 0.000000 0.000000 
200 0.000000 0.000000 0.000000 
300 0.020644 0.068814 0.004872 
400 0.116279 0.290698 0.004006 
500 0.212539 0.425079 0.004519 
600 0.308878 0.514796 0.004942 
700 0.404952 0.578502 0.004965 
800 0.501089 0.626362 0.004903 
900 0.597250 0.663611 0.004919 
1000 0.693818 0.693818 0.005447 
The above table shows the simulation results of clearance between the top of injury pad and glass 
substrate to a degenerative loading response of 10 psi where the notches are for a gap length of 10 µm 
and pedestal length of 20 µm. In the case of 100 nm and 200 nm a total collapse is seen and a minimum 
of 300 nm is needed. Hence 400 nm was chosen as the minimum height required for notches. 
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The valves were subject to compression for a period over 24 hours and prior to 
decompressing them FITC-PLL from all the chambers was aspirated and the chambers 
were washed with molecular grade water thrice. Images were taken both with compressed 
and uncompressed valves (figure 4.9) and a reliable pattern of notches were seen on the 
glass substrate without any loss in the structural and mechanical integrity of the valves. 
This proves that axons could be subject to a constant compression injury to model. 
 
4.2.3.4 Imaging neurofilaments and microtubules 
Cytoskeletal tranport network: neurofilaments (NT) and microtubules (MT) of an 
axon are disrupted during TAI. It is vital to study the disruption of this network during and 
post injury. In order to visualize these proteins under microscope rat E17 1o hippocampal 
neurons were transfected with phosphorylated cytomegalovirus (pCMV)-AC-green 
fluorescent protein (GFP) plasmids with a C-terminal TurboGFP (Origene, Rockville, MD, 
USA), encoding an NF-GFP or MT- associated protein tau (Mapt)-GFP fusion gene. To 
localize the cytoskeletal proteins NT or MT with the membrane of axon CMPTx red cell 
Fig 4.9: a) Uncompressed notch valve: the channels were filled with FITC-PLL and incubated overnight 
to take the images, b) compressed notch valve: valves were compressed prior to flushing the chambers 
with FITC-PLL, incubated overnight and washed before release of valve. One can clearly visualize the 
clear zones where the pedestal made contact with glass substrate for the entire duration of coating. 
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tracker (Gibco Life Technologies) was added prior to imaging with high resolution 
confocal microscopy. MATLAB was used for image processing of the acquired images 
(figure 4.10). The ability to image individual cytoskeletal components during TAI in 
combination with modified AIM device provides a powerful tool to study the time course 
of primary and secondary insults during TAI.  
 
4.2.4. Discussions 
TAI occurring in the settings of traumatic brain injury and spinal cord injury can 
be the result of insults of various kind. Amongst those various modes of insults 
compression is one. In TAI compression can vary from just deformation to complete 
transection of axon. TAI resulting from compression injury was earlier established and 
studied in giant squid axons. Giant squid axons are rendered easy to handle because of their 
large size (>0.5 mm in diameter). Initial experiments with these axons gave insights into 
Fig 4.10: a) Confocal images of GFP tagged microtubules (green) with respect to axonal membrane (red) 
labelled with CMPTx red cell tracker. Microtubules appear to be more localized with in the axon with an 
average diameter around 25nm, b) confocal images of GFP tagged neurofilaments (green) with respect 
to axonal membrane (red) labelled with CMPTx red cell tracker. Neurofilaments appear to be more 
dispersed within the axon with an average diameter around 10-12nm. (Axes scale in nm) 
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the compression injuries in axons but these studies cannot shed light on the mechanical 
characteristics of CNS cells. Also, CNS axons are very small in comparison to giant squid 
axons and very delicate to handle with. It has been widely accepted that changes to the 
cytoskeletal structure within axons are the primary means for axonal collapse following 
injury. Actin filaments, intermediate (neuro-) filaments, microtubules, and cross-linking 
proteins collectively are responsible for the structural properties of the neuronal axon. 
While the cytoskeletal network contribution has been accepted, the mechanisms by which 
this structure degrades and the contribution of each cytoskeletal components is not 
understood. Insight into the structural mechanics of these alterations will lead to a more 
complete comprehension of neural axon cellular integrity. 
 
Not all injuries lead to complete transection of axons. Some compressive injuries 
like carpal tunnel syndrome (CTS) [186] are chronic which result in repeated deformation 
of the axons or nerves under compression. An in vitro microfluidic injury platform to model 
and study repeated compressive injury, with control over the duration of injury being 
delivered, can effectively reproduce biochemical and mechanical events undergoing during 
pathologies like CTS. Such platform would serve as a powerful tool for critical study of 
various pathologies involving repeated compressive injuries. Modification of the injury 
pad in previously developed AIM platform can potentially address this issue. This 
modification can facilitate compression of axons to different degrees via displacement 
control for extended times of up to 16 hours or more. Moreover this method is both 
quantitative and qualitative. Quantitative in studying the relation of degree of displacement 
to axonal response, cytoskeletal response and reorganization, and transport disruptions. 
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The valves designed for TAI platform in AIM device were thus modified to 
incorporate gaps and pedestals. When the valve is compressed under pressure the pedestals 
contact the substrate and the gaps between them form notches under which axons can pass. 
The axons passing through these gaps are compressed to various degrees based on the 
diameter of the axons and notch clearance. In order to make these changes in valve design 
an additional layer is added to the master template between layer 2 and layer 3 which 
defines the notch clearance. 
 
A range of submicron notch height clearance was defined in various master 
templates. But defining these notches on master templates was very tricky. Notch below 
0.75 µm were not observed in master templates. This may be due to adhesion 
incompatibility between SU8 2000.5 (layer 3), SU8 3005 (layer 1, 2), and SU8 3050 (layer 
4) layers. Trail runs in master template fabrication were run with dilutions of SU8 3005 in 
cyclohexanone to achieve solid ratios of the resist comparable to that in SU8 2000.5 to 
improve the adhesion compatibility with other layers but this did not seem to have any 
effect on the formation of notches. The process had to be sufficiently modified by 
increasing the surface roughness of the layers below notches. 
 
Devices created were tested for formation of notches in PDMS. FITC-PLL in the 
devices coated the surfaces under the gaps only and not the pedestals indicating that axons 
can potentially pass under the gap regions and be compressed to various degrees depending 
on the notch clearance when the valve is compressed. Simultaneously, before any 
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experiments could be performed in these devices imaging modalities have to be developed 
or modified. In order to image the sub cellular aspects of axons like cytoskeletal and 
transport components sufficient imaging modalities like spinning confocal microscopy was 
used successfully in the already existing TAI platforms. Over all this device can be further 
integrated with imaging modalities to observe the sub-cellular changes in compressively 
deformed axons at extended time periods in the lab. 
 
4.2.5. Conclusions 
This study aims at modifying existing TAI platform to study chronic and repetitive 
compressive insults to axons and study the changes in cytoskeleton, transport systems, and 
axonal fate. This was planned to achieve by incorporating notches in the existing valves 
using gaps in the valve. Notch heights define the clearance from the substrate on which the 
axons grow which gives insights into the effect of degree of deformation on the fate of 
axons after injury. This is a very simple modification to the existing device by adding an 
additional layer to master template to define notch clearance. Initial experiments show that 





In this chapter I briefly present the results, and contributions resulting from the 
studies reported in chapters 3 and 4 of this thesis. It also includes the future directions that 
these results can lead to in order to advance the science and technology directed at solving 
problems at the heart of the field. 
 
5.1. Contributions from Aim 1:  
5.1.1. Technical and Scientific Achievements 
In chapter 3, which deals with my aim 1, I have descried the study dealing with the 
role of GDNF family neurotrophic factors GDNF, neurturin, and neublastin, in axonal 
regeneration, post injury. To study was conducted on rat DRG neurons in simple two 
chambered, open system microfluidic devices. The open system architecture of the 
microfluidic device supports better gaseous exchange compared to its closed system 
counterparts. Open system also supports the reduction in shear forces associated with 
media exchange/replenishment. To study the influence of microenvironment in axonal 
regeneration post injury, fluidic isolation between cell body and axonal compartments is a 
necessity. I achieved this required fluidic isolation by establishing hydrostatic pressure 
difference between the two chambers that counteracts mass transfer by advection and 
diffusion phenomena. The established gradient was stable for the entire duration of 
experiment (over 72 hours). While fluidic isolation is in effect, I demonstrated that GDNF 
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applied locally to cell body side promotes growth of axon after injury in a better way 
compared to when applied locally in axonal compartment. This led to a hypothesis that the 
observed difference in growth rate might be due to the fact that the GDNF signal is to be 
relayed to cell body via retrograde axonal transport to initiate the influence of GDNF on 
axonal growth. To test this hypothesis I used retrograde transport blocker Cytochalasin D 
along with GDNF. The presence of retrograde transport blocker further suppressed the rate 
of axonal growth post injury conforming my hypothesis.. 
  
5.1.2. Dissemination of original research 
The work mentioned in chapter 3 is culminating into a publication in a journal soon. 
While the manuscript is under preparation the results observed in dissociated DRG neurons 
are being translated at tissue levels in vitro.  
. 
5.2. Contributions from Aim 2:  
5.2.1. Technical and Scientific Achievements 
In chapter 4, which deals with my aim 2, I have described two possible directions 
for further developing existing AIM device to study TAI and carried out preliminary work, 
which has a great potential to be refined and furthered. One of the possible directions that 
I considered was to transform the AIM device developed by Hosmane et al. [61] into a 3D 
platform. Such transformation would provide strong relevance to the physiological 
conditions, for example brain tissue is soft while the axons in AIM are compressed against 
rigid glass substrate which may not be true reflection of the physiological scenario. Also, 
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this transformation would eliminate the complexities involved at tissue levels while 
permitting a study that closely mimics the mechanical nature of a tissue. In order to achieve 
this I developed an extra layer and named it the ECM layer. This layer had long and wide 
channels which are out of the regime of microfluidics. The channels were designed in such 
a way that the aspect ratio of height to width is less, this allows establishment of stable 
soluble gradients, a phenomenon observed in vivo. I established gels in those 
microchannels which would act as substrates for neurons to grow on. Though this is not a 
true 3D architecture per se, in essence it would pseudo 3D system that would mimic the 
mechanical properties of soft tissue. With this experimental plan I set out to culture rat E17 
1o hippocampal cells on the methacrylated hydrogels in these devices. Soon, issues with 
the compatibility between cell and hydrogels arose. I have attempted several iterations and 
various combinations of ECM to improve compatibility but noting seem to work. One 
interesting thing to note here is that Fan  et al. [187] were able to achieve good 
compatibility between methacyrlated gelatin hydrogels and rat cortical cells. I tried using 
cortical cells but they did not show better compatibility either. 
 
The second direction that I was considering was to modify the architecture of injury 
pad itself, of the AIM platform. The idea was to modify the injury pad such that the axons 
are subject to partial compression rather than complete transection, when the pad is fully 
compressed. In other words, the injury is dictated by the displacement caused by the pad 
rather than the load it delivers. This modality of injury inflection can be extended for 
prolonged durations so as to establish in vitro microfluidic models of pathologies like 
carpal tunnel syndrome. In order to achieve this, I incorporated an additional layer in the 
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master template of fluidic layer and termed this layer as the notch layer. With this 
modification Incorporation of this notch layer required spinning and photolithography of 
submicron thick layer. Though a challenge in itself, I could successfully achieve clearances 
in the range 500-1000 nm. This range was chosen assuming that the average diameter of a 
CNS axon to be 1000 nm. Though actual experiments could not be conducted with this 
platform the potential that it could offer is quite evident and could be taken up in the near 
future. 
 
5.2.2. Dissemination of original research  
Preliminary results from the first part of the work mentioned in chapter 4 was 
presented in a poster session of BMES conference 2012, held at Atlanta, Georgia. 
Likewise, preliminary results leading up to the second part of the work mentioned in 
chapter 4 was presented in a talk series of Society for Engineering  2012, held at Atlanta, 
Georgia. 
 
5.3 Future directions 
In this concluding section, I try to list few possible future directions to the work 
mentioned in earlier chapters 3 and 4. These possible future outcomes can broaden the 
horizons of LOC devices in neuroengineering applications and neuroscience as a whole. I 
hope that the future of neuroscience is dictated by the miniaturization of tools currently 
being like the semiconductor revolution to for computers which started out with beasts like 




5.3.1 Neurotrophic factors and functional nerve regeneration  
One of the possible future directions is to employ neurotrophic factors in nerve 
repair and functional nerve regeneration. Neurotrophic factors are a promising area of 
research for understanding axonal regeneration. Their role in providing trophic support 
during development and in maintenance of neurons has long been known, but elucidating 
their roles in regeneration may prove fruitful in the development of therapies for 
overcoming neural degeneration and enhancing regeneration post injury. 
 
Understanding axon specific or cell body specific effects of growth factors and 
being able to distinguish between local effects and retrograde signaling will be necessary 
for any future therapies. Compartmentalized microfluidic culture devices may be 
instrumental in these studies, but caution must be exercised to better characterize the 
devices to ensure true microfluidic separation of chambers. Role of these growth factors 
can be studied in more complex systems which involve tissue cultures, organotypic cultures 
and at the ultimate level in vivo studies. Initiatives towards in vivo study of growth factors 
like GDNF is already being taken up by couple of groups in rodents in peripheral nervous 
system [188, 189]  
 
Treatment strategies can combine stable establishment of local gradients of 
neurotrophic factors by systemic injection along with stimulation of oligodendrocytes or 
Schwann cell to provide conduits to the regenerating axons. The presence of Schwann cells 
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and their establishment of stable conduits protects the regenerating axons and they shield 
the axon from encountering inhibitory cues that will decrease the effective growth rate of 
axons and nerves. Another challenge that is to be tackled is to keep the distal part of the 
nerve conduit from degenerating while the proximal part grows in length to reestablish 
functional connectivity. Once again, local establishment of gradients and neurotrophic cues 
can be exploited to recruit Schwann cells and debris clearing cells. Microfluidics might 
soon offer platforms that allow studies involving regeneration and mylenation while 
maintaining stable and sustained gradients in cultures. And these strategies can then be 
translated in vivo.  
 
5.3.2 Secondary Injury and axonal transportation 
In TAI, usually a primary insult is followed upon by a much serious and often 
debilitating secondary injury which involves changes ranging from intracellular [Ca2+] 
level changes to cytoskeletal reorganizations. These may be associated with a form of 
memory with these insults in case of prolonged and repeated injuries. Intracellular calcium 
levels have be shown to be associated with secondary injury mechanisms in various studies 
[190-192]. These studies were done without compartmentalization of axons from cell body. 
This implies the need for exploration and tracking of the time course of intracellular [Ca2+] 
levels in axon independent of cell body during the time course of injury in different injury 
modalities. With the existing AIM platform and the modifications that I tried to accomplish 




In order to do this, the first and foremost thing that one would want to focus is on 
modifying the surface chemistry of the hydrogels, to improve the compatibility issues 
encountered between hydrogels and neurons. Once this is sorted out one could potentially 
look at the relationship of stiffness of the hydrogel surface to the thresholds of axonal 
regeneration after injury and subsequently study the intracellular [Ca2+] dynamics..Further, 
microglia can be incorporated in these gels to improve debris clearance after injury and 
study the changes in regeneration. Also, comparative studies between stiffness of the 
hydrogels and intracellular Ca2+ concentration changes in the injured axons can be 
potentially studied. I believe that the monitoring of extracellular field potential during the 
time course of an injury is an important aspect. As there is the intracellular [Ca2+] levels 
the membrane potential is potentially altered which will contribute to the opening and 
closing of several ion channels in the membrane which could be caught in the extra cellular 
field potentials. Integrating microfluidic devices with multi electrode arrays (MEA) or any 
other electrodes can facilitate additional information related to axonal injury.  
 
I also believe that the notch device could be combined with the other two devices 
in various combinations to conduct interesting experiments where axons could be subject 
to displacement controlled injuries. These studies would shed light at the cytoskeletal 
reorganization and transport disruption and axonal growth in chronic injuries. I have 
conducted preliminary experiments on neurofilaments and microtubules in collaboration. 
These preliminary results were a result of developing a technique to image cytoskeletal 




5.3.3 Hybrid and  in vivo microfluidic technologies 
I envision that the day when implantable microfluidic devices are a reality is in near 
future. The miniature size of the microfluidic devices makes them a suitable candidate for 
in vivo monitoring and therapeutic devices.Most commonly used polymer, PDMS for 
microfluidic devices is biocompatible and flexible which makes it suitable material for 
implants. Apart from biocompatibility and flexibility, the ability for rapid prototyping, cost 
effectiveness makes PDMS a powerful material for implantable microfluidic devices for 
neurological applications. 
 
Before the above mentioned could be successfully achieved one need to make 
progress in developing hybrid microfluidic platforms to maintain cultures with tissue and 
organ level organization and sophistication. To achieve the sophistication required for a 
organ level culture several types of microfluidic platforms mentioned in chapter 1 needs to 
be integrated. And I believe that this is going to be a major area of research in microfluidics 
and neuroengineering in the coming years. 















Bake the substrate @200 OC on hot plate 
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(If the resist layer is thick and the features are of 
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1 SU8 can be diluted to decrease the viscosity in case there is no resist available for spin 
coating a layer of desired thickness. 
2 Commonly used solvents for dilution are cyclopentanone or the commercially available 
SU8 thinner marketed by Microchem. 
3 Dilutions can be made either by viscosity or the total solid content in the resist. 
4 Take little less than the measure amount of the solvent in a beaker and keep stirring. 
5 Add the required amount of desired the photoresist while stirring the solvent 
continuously. 
6 Add the remaining solvent, this way you can ensure to wash and dissolve any 
photoresist sticking to the walls of the beaker. 
7 Close the beaker with an aluminum foil and keep stirring continuously for 30 min. 
8 Make sure that the temperature is low so that the evaporation could be minimized and 
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